"","STUDYID","SUBJID","AGE","STR01","STR01N","STR01L","STR02","STR02N","STR02L","TRT01P","TRT01PN","PARAM","PARAMCD","AVAL","CNSR","CNSDTDSC","DCTREAS"
"1","PSIVISSIG0002",1,33,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"2","PSIVISSIG0002",2,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1101,1,"Censored at the last contact date","ADVERSE EVENT"
"3","PSIVISSIG0002",3,33,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1771,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"4","PSIVISSIG0002",4,47,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",289,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"5","PSIVISSIG0002",5,48,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",388,1,"Censored at the last contact date","ADVERSE EVENT"
"6","PSIVISSIG0002",6,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1587,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"7","PSIVISSIG0002",7,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",117,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"8","PSIVISSIG0002",8,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1330,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"9","PSIVISSIG0002",9,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1411,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"10","PSIVISSIG0002",10,30,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"11","PSIVISSIG0002",11,65,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",975,1,"Censored at the last contact date","ADVERSE EVENT"
"12","PSIVISSIG0002",12,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",309,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"13","PSIVISSIG0002",13,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",412,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"14","PSIVISSIG0002",14,38,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1501,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"15","PSIVISSIG0002",15,56,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",21,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"16","PSIVISSIG0002",16,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",151,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"17","PSIVISSIG0002",17,60,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",124,1,"Censored at the last contact date","ADVERSE EVENT"
"18","PSIVISSIG0002",18,53,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",560,1,"Censored at the last contact date","ADVERSE EVENT"
"19","PSIVISSIG0002",19,56,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",169,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"20","PSIVISSIG0002",20,47,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",179,1,"Censored at the last contact date","DEATH"
"21","PSIVISSIG0002",21,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",272,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"22","PSIVISSIG0002",22,35,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1205,1,"Censored at the last contact date","ADVERSE EVENT"
"23","PSIVISSIG0002",23,41,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1093,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"24","PSIVISSIG0002",24,49,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",680,1,"Censored at the last contact date","ADVERSE EVENT"
"25","PSIVISSIG0002",25,31,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",28,1,"Censored at the last contact date","ADVERSE EVENT"
"26","PSIVISSIG0002",26,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"27","PSIVISSIG0002",27,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",26,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"28","PSIVISSIG0002",28,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",994,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"29","PSIVISSIG0002",29,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"30","PSIVISSIG0002",30,54,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",749,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"31","PSIVISSIG0002",31,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",32,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"32","PSIVISSIG0002",32,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"33","PSIVISSIG0002",33,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",98,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"34","PSIVISSIG0002",34,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"35","PSIVISSIG0002",35,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",851,1,"Censored at the last contact date","ADVERSE EVENT"
"36","PSIVISSIG0002",36,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1593,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"37","PSIVISSIG0002",37,44,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",311,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"38","PSIVISSIG0002",38,47,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"39","PSIVISSIG0002",39,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"40","PSIVISSIG0002",40,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",655,1,"Censored at the last contact date","ADVERSE EVENT"
"41","PSIVISSIG0002",41,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",292,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"42","PSIVISSIG0002",42,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",213,1,"Censored at the last contact date","ADVERSE EVENT"
"43","PSIVISSIG0002",43,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",111,1,"Censored at the last contact date","ADVERSE EVENT"
"44","PSIVISSIG0002",44,58,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"45","PSIVISSIG0002",45,59,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",163,1,"Censored at the last contact date","ADVERSE EVENT"
"46","PSIVISSIG0002",46,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",224,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"47","PSIVISSIG0002",47,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",434,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"48","PSIVISSIG0002",48,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",267,1,"Censored at the last contact date","ADVERSE EVENT"
"49","PSIVISSIG0002",49,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",491,1,"Censored at the last contact date","ADVERSE EVENT"
"50","PSIVISSIG0002",50,55,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",0,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"51","PSIVISSIG0002",51,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",108,1,"Censored at the last contact date","ADVERSE EVENT"
"52","PSIVISSIG0002",52,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"53","PSIVISSIG0002",53,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",147,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"54","PSIVISSIG0002",54,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",734,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"55","PSIVISSIG0002",55,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",695,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"56","PSIVISSIG0002",56,52,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",985,1,"Censored at the last contact date","ADVERSE EVENT"
"57","PSIVISSIG0002",57,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",18,1,"Censored at the last contact date","ADVERSE EVENT"
"58","PSIVISSIG0002",58,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",27,1,"Censored at the last contact date","DEATH"
"59","PSIVISSIG0002",59,34,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",860,1,"Censored at the last contact date","ADVERSE EVENT"
"60","PSIVISSIG0002",60,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"61","PSIVISSIG0002",61,50,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1125,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"62","PSIVISSIG0002",62,59,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",324,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"63","PSIVISSIG0002",63,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",890,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"64","PSIVISSIG0002",64,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",426,1,"Censored at the last contact date","DEATH"
"65","PSIVISSIG0002",65,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",246,1,"Censored at the last contact date","ADVERSE EVENT"
"66","PSIVISSIG0002",66,22,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1726,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"67","PSIVISSIG0002",67,59,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",140,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"68","PSIVISSIG0002",68,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",147,1,"Censored at the last contact date","ADVERSE EVENT"
"69","PSIVISSIG0002",69,35,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1603,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"70","PSIVISSIG0002",70,46,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",44,1,"Censored at the last contact date","ADVERSE EVENT"
"71","PSIVISSIG0002",71,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",819,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"72","PSIVISSIG0002",72,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",469,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"73","PSIVISSIG0002",73,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"74","PSIVISSIG0002",74,63,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",801,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"75","PSIVISSIG0002",75,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1405,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"76","PSIVISSIG0002",76,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",784,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"77","PSIVISSIG0002",77,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",785,1,"Censored at the last contact date","ADVERSE EVENT"
"78","PSIVISSIG0002",78,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"79","PSIVISSIG0002",79,58,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1062,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"80","PSIVISSIG0002",80,40,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",82,1,"Censored at the last contact date","ADVERSE EVENT"
"81","PSIVISSIG0002",81,33,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"82","PSIVISSIG0002",82,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",135,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"83","PSIVISSIG0002",83,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"84","PSIVISSIG0002",84,61,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1153,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"85","PSIVISSIG0002",85,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",396,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"86","PSIVISSIG0002",86,30,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1691,1,"Censored at the last contact date","ADVERSE EVENT"
"87","PSIVISSIG0002",87,40,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1614,1,"Censored at the last contact date","ADVERSE EVENT"
"88","PSIVISSIG0002",88,47,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",731,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"89","PSIVISSIG0002",89,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",657,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"90","PSIVISSIG0002",90,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",808,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"91","PSIVISSIG0002",91,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"92","PSIVISSIG0002",92,55,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",71,1,"Censored at the last contact date","DEATH"
"93","PSIVISSIG0002",93,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1497,1,"Censored at the last contact date","ADVERSE EVENT"
"94","PSIVISSIG0002",94,34,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",977,1,"Censored at the last contact date","ADVERSE EVENT"
"95","PSIVISSIG0002",95,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"96","PSIVISSIG0002",96,59,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"97","PSIVISSIG0002",97,39,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",842,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"98","PSIVISSIG0002",98,24,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",25,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"99","PSIVISSIG0002",99,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",237,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"100","PSIVISSIG0002",100,58,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"101","PSIVISSIG0002",101,38,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1015,1,"Censored at the last contact date","ADVERSE EVENT"
"102","PSIVISSIG0002",102,47,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"103","PSIVISSIG0002",103,57,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",438,1,"Censored at the last contact date","ADVERSE EVENT"
"104","PSIVISSIG0002",104,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1326,1,"Censored at the last contact date","ADVERSE EVENT"
"105","PSIVISSIG0002",105,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1546,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"106","PSIVISSIG0002",106,59,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",79,1,"Censored at the last contact date","ADVERSE EVENT"
"107","PSIVISSIG0002",107,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",744,1,"Censored at the last contact date","ADVERSE EVENT"
"108","PSIVISSIG0002",108,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1249,1,"Censored at the last contact date","ADVERSE EVENT"
"109","PSIVISSIG0002",109,44,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",801,1,"Censored at the last contact date","ADVERSE EVENT"
"110","PSIVISSIG0002",110,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1741,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"111","PSIVISSIG0002",111,51,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",631,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"112","PSIVISSIG0002",112,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",484,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"113","PSIVISSIG0002",113,44,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",610,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"114","PSIVISSIG0002",114,36,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",626,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"115","PSIVISSIG0002",115,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"116","PSIVISSIG0002",116,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",274,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"117","PSIVISSIG0002",117,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",307,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"118","PSIVISSIG0002",118,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1207,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"119","PSIVISSIG0002",119,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"120","PSIVISSIG0002",120,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"121","PSIVISSIG0002",121,58,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",169,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"122","PSIVISSIG0002",122,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1614,1,"Censored at the last contact date","ADVERSE EVENT"
"123","PSIVISSIG0002",123,27,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1277,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"124","PSIVISSIG0002",124,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",727,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"125","PSIVISSIG0002",125,52,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",304,1,"Censored at the last contact date","ADVERSE EVENT"
"126","PSIVISSIG0002",126,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1232,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"127","PSIVISSIG0002",127,35,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1400,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"128","PSIVISSIG0002",128,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"129","PSIVISSIG0002",129,52,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",561,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"130","PSIVISSIG0002",130,59,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",779,1,"Censored at the last contact date","ADVERSE EVENT"
"131","PSIVISSIG0002",131,41,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1050,1,"Censored at the last contact date","ADVERSE EVENT"
"132","PSIVISSIG0002",132,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",639,1,"Censored at the last contact date","DEATH"
"133","PSIVISSIG0002",133,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",828,1,"Censored at the last contact date","ADVERSE EVENT"
"134","PSIVISSIG0002",134,38,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"135","PSIVISSIG0002",135,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",679,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"136","PSIVISSIG0002",136,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",744,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"137","PSIVISSIG0002",137,41,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",557,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"138","PSIVISSIG0002",138,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"139","PSIVISSIG0002",139,65,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"140","PSIVISSIG0002",140,39,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1622,1,"Censored at the last contact date","ADVERSE EVENT"
"141","PSIVISSIG0002",141,53,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1195,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"142","PSIVISSIG0002",142,37,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",87,1,"Censored at the last contact date","ADVERSE EVENT"
"143","PSIVISSIG0002",143,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",299,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"144","PSIVISSIG0002",144,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",41,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"145","PSIVISSIG0002",145,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",618,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"146","PSIVISSIG0002",146,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",72,1,"Censored at the last contact date","ADVERSE EVENT"
"147","PSIVISSIG0002",147,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"148","PSIVISSIG0002",148,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",228,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"149","PSIVISSIG0002",149,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",653,1,"Censored at the last contact date","DEATH"
"150","PSIVISSIG0002",150,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",86,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"151","PSIVISSIG0002",151,28,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",739,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"152","PSIVISSIG0002",152,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",122,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"153","PSIVISSIG0002",153,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",276,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"154","PSIVISSIG0002",154,51,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1083,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"155","PSIVISSIG0002",155,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"156","PSIVISSIG0002",156,33,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",273,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"157","PSIVISSIG0002",157,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",665,1,"Censored at the last contact date","ADVERSE EVENT"
"158","PSIVISSIG0002",158,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"159","PSIVISSIG0002",159,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",970,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"160","PSIVISSIG0002",160,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",416,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"161","PSIVISSIG0002",161,47,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",688,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"162","PSIVISSIG0002",162,55,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1053,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"163","PSIVISSIG0002",163,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1727,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"164","PSIVISSIG0002",164,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",264,1,"Censored at the last contact date","ADVERSE EVENT"
"165","PSIVISSIG0002",165,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",181,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"166","PSIVISSIG0002",166,34,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",735,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"167","PSIVISSIG0002",167,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",411,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"168","PSIVISSIG0002",168,40,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",28,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"169","PSIVISSIG0002",169,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"170","PSIVISSIG0002",170,41,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",13,1,"Censored at the last contact date","ADVERSE EVENT"
"171","PSIVISSIG0002",171,43,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",642,1,"Censored at the last contact date","ADVERSE EVENT"
"172","PSIVISSIG0002",172,64,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",207,1,"Censored at the last contact date","ADVERSE EVENT"
"173","PSIVISSIG0002",173,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",120,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"174","PSIVISSIG0002",174,43,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",122,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"175","PSIVISSIG0002",175,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1497,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"176","PSIVISSIG0002",176,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1606,1,"Censored at the last contact date","ADVERSE EVENT"
"177","PSIVISSIG0002",177,47,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",968,1,"Censored at the last contact date","ADVERSE EVENT"
"178","PSIVISSIG0002",178,31,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"179","PSIVISSIG0002",179,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",502,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"180","PSIVISSIG0002",180,29,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"181","PSIVISSIG0002",181,17,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",744,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"182","PSIVISSIG0002",182,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1338,1,"Censored at the last contact date","ADVERSE EVENT"
"183","PSIVISSIG0002",183,54,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",223,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"184","PSIVISSIG0002",184,29,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1260,1,"Censored at the last contact date","ADVERSE EVENT"
"185","PSIVISSIG0002",185,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1114,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"186","PSIVISSIG0002",186,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",929,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"187","PSIVISSIG0002",187,34,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1349,1,"Censored at the last contact date","ADVERSE EVENT"
"188","PSIVISSIG0002",188,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"189","PSIVISSIG0002",189,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"190","PSIVISSIG0002",190,29,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"191","PSIVISSIG0002",191,56,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",557,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"192","PSIVISSIG0002",192,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",660,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"193","PSIVISSIG0002",193,56,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"194","PSIVISSIG0002",194,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",461,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"195","PSIVISSIG0002",195,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",332,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"196","PSIVISSIG0002",196,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",986,1,"Censored at the last contact date","ADVERSE EVENT"
"197","PSIVISSIG0002",197,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1276,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"198","PSIVISSIG0002",198,42,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1623,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"199","PSIVISSIG0002",199,21,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",930,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"200","PSIVISSIG0002",200,31,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",543,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"201","PSIVISSIG0002",201,29,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1534,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"202","PSIVISSIG0002",202,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",149,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"203","PSIVISSIG0002",203,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",239,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"204","PSIVISSIG0002",204,55,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",953,1,"Censored at the last contact date","ADVERSE EVENT"
"205","PSIVISSIG0002",205,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"206","PSIVISSIG0002",206,42,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",85,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"207","PSIVISSIG0002",207,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",548,1,"Censored at the last contact date","ADVERSE EVENT"
"208","PSIVISSIG0002",208,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"209","PSIVISSIG0002",209,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1282,1,"Censored at the last contact date","DEATH"
"210","PSIVISSIG0002",210,29,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",498,1,"Censored at the last contact date","DEATH"
"211","PSIVISSIG0002",211,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",44,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"212","PSIVISSIG0002",212,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1134,1,"Censored at the last contact date","ADVERSE EVENT"
"213","PSIVISSIG0002",213,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",81,1,"Censored at the last contact date","DEATH"
"214","PSIVISSIG0002",214,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",125,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"215","PSIVISSIG0002",215,58,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",87,1,"Censored at the last contact date","ADVERSE EVENT"
"216","PSIVISSIG0002",216,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",80,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"217","PSIVISSIG0002",217,47,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1002,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"218","PSIVISSIG0002",218,37,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",571,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"219","PSIVISSIG0002",219,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"220","PSIVISSIG0002",220,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",212,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"221","PSIVISSIG0002",221,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1432,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"222","PSIVISSIG0002",222,28,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",125,1,"Censored at the last contact date","ADVERSE EVENT"
"223","PSIVISSIG0002",223,58,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",487,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"224","PSIVISSIG0002",224,51,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1645,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"225","PSIVISSIG0002",225,39,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",190,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"226","PSIVISSIG0002",226,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"227","PSIVISSIG0002",227,38,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",299,1,"Censored at the last contact date","ADVERSE EVENT"
"228","PSIVISSIG0002",228,42,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",26,1,"Censored at the last contact date","ADVERSE EVENT"
"229","PSIVISSIG0002",229,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1572,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"230","PSIVISSIG0002",230,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",769,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"231","PSIVISSIG0002",231,54,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",246,1,"Censored at the last contact date","ADVERSE EVENT"
"232","PSIVISSIG0002",232,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1104,1,"Censored at the last contact date","ADVERSE EVENT"
"233","PSIVISSIG0002",233,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"234","PSIVISSIG0002",234,49,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"235","PSIVISSIG0002",235,31,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",197,1,"Censored at the last contact date","ADVERSE EVENT"
"236","PSIVISSIG0002",236,59,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",817,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"237","PSIVISSIG0002",237,28,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",306,1,"Censored at the last contact date","ADVERSE EVENT"
"238","PSIVISSIG0002",238,41,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"239","PSIVISSIG0002",239,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",184,1,"Censored at the last contact date","ADVERSE EVENT"
"240","PSIVISSIG0002",240,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"241","PSIVISSIG0002",241,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1358,1,"Censored at the last contact date","ADVERSE EVENT"
"242","PSIVISSIG0002",242,60,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",156,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"243","PSIVISSIG0002",243,57,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",941,1,"Censored at the last contact date","ADVERSE EVENT"
"244","PSIVISSIG0002",244,48,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",904,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"245","PSIVISSIG0002",245,47,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"246","PSIVISSIG0002",246,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",160,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"247","PSIVISSIG0002",247,55,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",484,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"248","PSIVISSIG0002",248,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",707,1,"Censored at the last contact date","ADVERSE EVENT"
"249","PSIVISSIG0002",249,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",603,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"250","PSIVISSIG0002",250,35,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",526,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"251","PSIVISSIG0002",251,37,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",998,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"252","PSIVISSIG0002",252,36,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"253","PSIVISSIG0002",253,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1748,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"254","PSIVISSIG0002",254,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",752,1,"Censored at the last contact date","ADVERSE EVENT"
"255","PSIVISSIG0002",255,45,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"256","PSIVISSIG0002",256,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",50,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"257","PSIVISSIG0002",257,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",487,1,"Censored at the last contact date","ADVERSE EVENT"
"258","PSIVISSIG0002",258,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"259","PSIVISSIG0002",259,64,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",436,1,"Censored at the last contact date","ADVERSE EVENT"
"260","PSIVISSIG0002",260,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",31,1,"Censored at the last contact date","ADVERSE EVENT"
"261","PSIVISSIG0002",261,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",281,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"262","PSIVISSIG0002",262,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",892,1,"Censored at the last contact date","ADVERSE EVENT"
"263","PSIVISSIG0002",263,20,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1112,1,"Censored at the last contact date","ADVERSE EVENT"
"264","PSIVISSIG0002",264,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",75,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"265","PSIVISSIG0002",265,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",166,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"266","PSIVISSIG0002",266,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"267","PSIVISSIG0002",267,38,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1308,1,"Censored at the last contact date","ADVERSE EVENT"
"268","PSIVISSIG0002",268,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",577,1,"Censored at the last contact date","ADVERSE EVENT"
"269","PSIVISSIG0002",269,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",287,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"270","PSIVISSIG0002",270,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"271","PSIVISSIG0002",271,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",200,1,"Censored at the last contact date","ADVERSE EVENT"
"272","PSIVISSIG0002",272,44,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"273","PSIVISSIG0002",273,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",468,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"274","PSIVISSIG0002",274,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",380,1,"Censored at the last contact date","ADVERSE EVENT"
"275","PSIVISSIG0002",275,41,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1342,1,"Censored at the last contact date","ADVERSE EVENT"
"276","PSIVISSIG0002",276,42,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",115,1,"Censored at the last contact date","ADVERSE EVENT"
"277","PSIVISSIG0002",277,35,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",391,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"278","PSIVISSIG0002",278,51,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",714,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"279","PSIVISSIG0002",279,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",753,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"280","PSIVISSIG0002",280,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",33,1,"Censored at the last contact date","DEATH"
"281","PSIVISSIG0002",281,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",552,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"282","PSIVISSIG0002",282,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",16,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"283","PSIVISSIG0002",283,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"284","PSIVISSIG0002",284,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"285","PSIVISSIG0002",285,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",530,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"286","PSIVISSIG0002",286,31,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",761,1,"Censored at the last contact date","ADVERSE EVENT"
"287","PSIVISSIG0002",287,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1677,1,"Censored at the last contact date","ADVERSE EVENT"
"288","PSIVISSIG0002",288,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"289","PSIVISSIG0002",289,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",928,1,"Censored at the last contact date","ADVERSE EVENT"
"290","PSIVISSIG0002",290,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1488,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"291","PSIVISSIG0002",291,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",621,1,"Censored at the last contact date","ADVERSE EVENT"
"292","PSIVISSIG0002",292,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",530,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"293","PSIVISSIG0002",293,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"294","PSIVISSIG0002",294,33,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"295","PSIVISSIG0002",295,38,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"296","PSIVISSIG0002",296,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",87,1,"Censored at the last contact date","ADVERSE EVENT"
"297","PSIVISSIG0002",297,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",402,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"298","PSIVISSIG0002",298,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",275,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"299","PSIVISSIG0002",299,55,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"300","PSIVISSIG0002",300,41,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"301","PSIVISSIG0002",301,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"302","PSIVISSIG0002",302,45,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",10,1,"Censored at the last contact date","ADVERSE EVENT"
"303","PSIVISSIG0002",303,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1644,1,"Censored at the last contact date","ADVERSE EVENT"
"304","PSIVISSIG0002",304,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",882,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"305","PSIVISSIG0002",305,27,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"306","PSIVISSIG0002",306,40,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",763,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"307","PSIVISSIG0002",307,56,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1283,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"308","PSIVISSIG0002",308,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"309","PSIVISSIG0002",309,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",243,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"310","PSIVISSIG0002",310,28,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"311","PSIVISSIG0002",311,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",102,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"312","PSIVISSIG0002",312,35,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"313","PSIVISSIG0002",313,52,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",153,1,"Censored at the last contact date","ADVERSE EVENT"
"314","PSIVISSIG0002",314,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",388,1,"Censored at the last contact date","ADVERSE EVENT"
"315","PSIVISSIG0002",315,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",676,1,"Censored at the last contact date","ADVERSE EVENT"
"316","PSIVISSIG0002",316,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",91,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"317","PSIVISSIG0002",317,64,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",811,1,"Censored at the last contact date","DEATH"
"318","PSIVISSIG0002",318,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",653,1,"Censored at the last contact date","ADVERSE EVENT"
"319","PSIVISSIG0002",319,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"320","PSIVISSIG0002",320,31,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"321","PSIVISSIG0002",321,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"322","PSIVISSIG0002",322,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",759,1,"Censored at the last contact date","ADVERSE EVENT"
"323","PSIVISSIG0002",323,36,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"324","PSIVISSIG0002",324,36,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1045,1,"Censored at the last contact date","ADVERSE EVENT"
"325","PSIVISSIG0002",325,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"326","PSIVISSIG0002",326,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",707,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"327","PSIVISSIG0002",327,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",801,1,"Censored at the last contact date","DEATH"
"328","PSIVISSIG0002",328,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"329","PSIVISSIG0002",329,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"330","PSIVISSIG0002",330,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",77,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"331","PSIVISSIG0002",331,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",266,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"332","PSIVISSIG0002",332,54,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",149,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"333","PSIVISSIG0002",333,51,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"334","PSIVISSIG0002",334,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"335","PSIVISSIG0002",335,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",306,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"336","PSIVISSIG0002",336,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",5,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"337","PSIVISSIG0002",337,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"338","PSIVISSIG0002",338,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",794,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"339","PSIVISSIG0002",339,29,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1089,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"340","PSIVISSIG0002",340,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",299,1,"Censored at the last contact date","ADVERSE EVENT"
"341","PSIVISSIG0002",341,34,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",480,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"342","PSIVISSIG0002",342,63,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1148,1,"Censored at the last contact date","ADVERSE EVENT"
"343","PSIVISSIG0002",343,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",601,1,"Censored at the last contact date","ADVERSE EVENT"
"344","PSIVISSIG0002",344,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"345","PSIVISSIG0002",345,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",242,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"346","PSIVISSIG0002",346,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1136,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"347","PSIVISSIG0002",347,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"348","PSIVISSIG0002",348,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",59,1,"Censored at the last contact date","ADVERSE EVENT"
"349","PSIVISSIG0002",349,31,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",659,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"350","PSIVISSIG0002",350,43,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",825,1,"Censored at the last contact date","DEATH"
"351","PSIVISSIG0002",351,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1454,1,"Censored at the last contact date","ADVERSE EVENT"
"352","PSIVISSIG0002",352,45,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",758,1,"Censored at the last contact date","ADVERSE EVENT"
"353","PSIVISSIG0002",353,64,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1023,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"354","PSIVISSIG0002",354,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",463,1,"Censored at the last contact date","ADVERSE EVENT"
"355","PSIVISSIG0002",355,56,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"356","PSIVISSIG0002",356,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",229,1,"Censored at the last contact date","ADVERSE EVENT"
"357","PSIVISSIG0002",357,39,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",345,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"358","PSIVISSIG0002",358,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"359","PSIVISSIG0002",359,41,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",368,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"360","PSIVISSIG0002",360,36,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1025,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"361","PSIVISSIG0002",361,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",766,1,"Censored at the last contact date","ADVERSE EVENT"
"362","PSIVISSIG0002",362,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",40,1,"Censored at the last contact date","ADVERSE EVENT"
"363","PSIVISSIG0002",363,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1349,1,"Censored at the last contact date","ADVERSE EVENT"
"364","PSIVISSIG0002",364,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"365","PSIVISSIG0002",365,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"366","PSIVISSIG0002",366,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",98,1,"Censored at the last contact date","ADVERSE EVENT"
"367","PSIVISSIG0002",367,62,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",250,1,"Censored at the last contact date","ADVERSE EVENT"
"368","PSIVISSIG0002",368,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",30,1,"Censored at the last contact date","ADVERSE EVENT"
"369","PSIVISSIG0002",369,31,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"370","PSIVISSIG0002",370,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1264,1,"Censored at the last contact date","ADVERSE EVENT"
"371","PSIVISSIG0002",371,46,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",347,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"372","PSIVISSIG0002",372,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",178,1,"Censored at the last contact date","ADVERSE EVENT"
"373","PSIVISSIG0002",373,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"374","PSIVISSIG0002",374,55,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",441,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"375","PSIVISSIG0002",375,51,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",171,1,"Censored at the last contact date","ADVERSE EVENT"
"376","PSIVISSIG0002",376,56,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"377","PSIVISSIG0002",377,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",147,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"378","PSIVISSIG0002",378,62,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",21,1,"Censored at the last contact date","ADVERSE EVENT"
"379","PSIVISSIG0002",379,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",93,1,"Censored at the last contact date","ADVERSE EVENT"
"380","PSIVISSIG0002",380,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"381","PSIVISSIG0002",381,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",755,1,"Censored at the last contact date","ADVERSE EVENT"
"382","PSIVISSIG0002",382,34,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"383","PSIVISSIG0002",383,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1109,1,"Censored at the last contact date","ADVERSE EVENT"
"384","PSIVISSIG0002",384,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",342,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"385","PSIVISSIG0002",385,26,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"386","PSIVISSIG0002",386,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",235,1,"Censored at the last contact date","ADVERSE EVENT"
"387","PSIVISSIG0002",387,52,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",136,1,"Censored at the last contact date","ADVERSE EVENT"
"388","PSIVISSIG0002",388,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",711,1,"Censored at the last contact date","ADVERSE EVENT"
"389","PSIVISSIG0002",389,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"390","PSIVISSIG0002",390,39,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",572,1,"Censored at the last contact date","ADVERSE EVENT"
"391","PSIVISSIG0002",391,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",141,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"392","PSIVISSIG0002",392,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1247,1,"Censored at the last contact date","DEATH"
"393","PSIVISSIG0002",393,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",401,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"394","PSIVISSIG0002",394,41,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",11,1,"Censored at the last contact date","ADVERSE EVENT"
"395","PSIVISSIG0002",395,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",362,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"396","PSIVISSIG0002",396,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1688,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"397","PSIVISSIG0002",397,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"398","PSIVISSIG0002",398,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1659,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"399","PSIVISSIG0002",399,41,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1369,1,"Censored at the last contact date","ADVERSE EVENT"
"400","PSIVISSIG0002",400,47,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",512,1,"Censored at the last contact date","ADVERSE EVENT"
"401","PSIVISSIG0002",401,61,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",186,1,"Censored at the last contact date","ADVERSE EVENT"
"402","PSIVISSIG0002",402,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",524,1,"Censored at the last contact date","ADVERSE EVENT"
"403","PSIVISSIG0002",403,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",70,1,"Censored at the last contact date","DEATH"
"404","PSIVISSIG0002",404,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"405","PSIVISSIG0002",405,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1062,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"406","PSIVISSIG0002",406,36,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"407","PSIVISSIG0002",407,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1176,1,"Censored at the last contact date","ADVERSE EVENT"
"408","PSIVISSIG0002",408,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",698,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"409","PSIVISSIG0002",409,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1225,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"410","PSIVISSIG0002",410,36,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",232,1,"Censored at the last contact date","ADVERSE EVENT"
"411","PSIVISSIG0002",411,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1003,1,"Censored at the last contact date","ADVERSE EVENT"
"412","PSIVISSIG0002",412,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",380,1,"Censored at the last contact date","ADVERSE EVENT"
"413","PSIVISSIG0002",413,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",15,1,"Censored at the last contact date","ADVERSE EVENT"
"414","PSIVISSIG0002",414,27,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"415","PSIVISSIG0002",415,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"416","PSIVISSIG0002",416,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",888,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"417","PSIVISSIG0002",417,62,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",907,1,"Censored at the last contact date","DEATH"
"418","PSIVISSIG0002",418,22,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1637,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"419","PSIVISSIG0002",419,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"420","PSIVISSIG0002",420,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",427,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"421","PSIVISSIG0002",421,35,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",391,1,"Censored at the last contact date","ADVERSE EVENT"
"422","PSIVISSIG0002",422,36,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1319,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"423","PSIVISSIG0002",423,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"424","PSIVISSIG0002",424,28,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"425","PSIVISSIG0002",425,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",894,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"426","PSIVISSIG0002",426,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"427","PSIVISSIG0002",427,34,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",807,1,"Censored at the last contact date","ADVERSE EVENT"
"428","PSIVISSIG0002",428,47,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"429","PSIVISSIG0002",429,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",226,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"430","PSIVISSIG0002",430,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",934,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"431","PSIVISSIG0002",431,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",520,1,"Censored at the last contact date","ADVERSE EVENT"
"432","PSIVISSIG0002",432,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",416,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"433","PSIVISSIG0002",433,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",471,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"434","PSIVISSIG0002",434,63,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",834,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"435","PSIVISSIG0002",435,51,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",995,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"436","PSIVISSIG0002",436,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",610,1,"Censored at the last contact date","ADVERSE EVENT"
"437","PSIVISSIG0002",437,55,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"438","PSIVISSIG0002",438,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",243,1,"Censored at the last contact date","ADVERSE EVENT"
"439","PSIVISSIG0002",439,39,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",639,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"440","PSIVISSIG0002",440,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",176,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"441","PSIVISSIG0002",441,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"442","PSIVISSIG0002",442,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"443","PSIVISSIG0002",443,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",703,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"444","PSIVISSIG0002",444,66,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"445","PSIVISSIG0002",445,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",727,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"446","PSIVISSIG0002",446,47,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",210,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"447","PSIVISSIG0002",447,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1046,1,"Censored at the last contact date","ADVERSE EVENT"
"448","PSIVISSIG0002",448,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",489,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"449","PSIVISSIG0002",449,58,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"450","PSIVISSIG0002",450,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",975,1,"Censored at the last contact date","ADVERSE EVENT"
"451","PSIVISSIG0002",451,54,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1358,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"452","PSIVISSIG0002",452,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",536,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"453","PSIVISSIG0002",453,55,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1276,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"454","PSIVISSIG0002",454,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1097,1,"Censored at the last contact date","ADVERSE EVENT"
"455","PSIVISSIG0002",455,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",100,1,"Censored at the last contact date","DEATH"
"456","PSIVISSIG0002",456,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",692,1,"Censored at the last contact date","ADVERSE EVENT"
"457","PSIVISSIG0002",457,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"458","PSIVISSIG0002",458,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",247,1,"Censored at the last contact date","ADVERSE EVENT"
"459","PSIVISSIG0002",459,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"460","PSIVISSIG0002",460,35,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",384,1,"Censored at the last contact date","DEATH"
"461","PSIVISSIG0002",461,41,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1335,1,"Censored at the last contact date","ADVERSE EVENT"
"462","PSIVISSIG0002",462,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1246,1,"Censored at the last contact date","ADVERSE EVENT"
"463","PSIVISSIG0002",463,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",245,1,"Censored at the last contact date","DEATH"
"464","PSIVISSIG0002",464,54,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",40,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"465","PSIVISSIG0002",465,41,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",409,1,"Censored at the last contact date","ADVERSE EVENT"
"466","PSIVISSIG0002",466,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",853,1,"Censored at the last contact date","ADVERSE EVENT"
"467","PSIVISSIG0002",467,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"468","PSIVISSIG0002",468,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",253,1,"Censored at the last contact date","DEATH"
"469","PSIVISSIG0002",469,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"470","PSIVISSIG0002",470,29,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",611,1,"Censored at the last contact date","ADVERSE EVENT"
"471","PSIVISSIG0002",471,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1388,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"472","PSIVISSIG0002",472,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",726,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"473","PSIVISSIG0002",473,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",167,1,"Censored at the last contact date","ADVERSE EVENT"
"474","PSIVISSIG0002",474,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1465,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"475","PSIVISSIG0002",475,53,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",351,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"476","PSIVISSIG0002",476,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1710,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"477","PSIVISSIG0002",477,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1664,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"478","PSIVISSIG0002",478,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",392,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"479","PSIVISSIG0002",479,56,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"480","PSIVISSIG0002",480,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",22,1,"Censored at the last contact date","DEATH"
"481","PSIVISSIG0002",481,59,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",32,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"482","PSIVISSIG0002",482,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",119,1,"Censored at the last contact date","DEATH"
"483","PSIVISSIG0002",483,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",51,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"484","PSIVISSIG0002",484,55,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",729,1,"Censored at the last contact date","ADVERSE EVENT"
"485","PSIVISSIG0002",485,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"486","PSIVISSIG0002",486,31,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",105,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"487","PSIVISSIG0002",487,57,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"488","PSIVISSIG0002",488,51,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",59,1,"Censored at the last contact date","ADVERSE EVENT"
"489","PSIVISSIG0002",489,33,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1098,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"490","PSIVISSIG0002",490,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",282,1,"Censored at the last contact date","DEATH"
"491","PSIVISSIG0002",491,32,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"492","PSIVISSIG0002",492,25,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"493","PSIVISSIG0002",493,57,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"494","PSIVISSIG0002",494,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"495","PSIVISSIG0002",495,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"496","PSIVISSIG0002",496,19,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"497","PSIVISSIG0002",497,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",90,1,"Censored at the last contact date","ADVERSE EVENT"
"498","PSIVISSIG0002",498,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"499","PSIVISSIG0002",499,27,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1030,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"500","PSIVISSIG0002",500,31,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1141,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"501","PSIVISSIG0002",501,26,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"502","PSIVISSIG0002",502,13,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",627,1,"Censored at the last contact date","ADVERSE EVENT"
"503","PSIVISSIG0002",503,28,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1069,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"504","PSIVISSIG0002",504,38,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1230,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"505","PSIVISSIG0002",505,56,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",255,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"506","PSIVISSIG0002",506,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",590,1,"Censored at the last contact date","ADVERSE EVENT"
"507","PSIVISSIG0002",507,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"508","PSIVISSIG0002",508,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1078,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"509","PSIVISSIG0002",509,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"510","PSIVISSIG0002",510,60,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"511","PSIVISSIG0002",511,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",245,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"512","PSIVISSIG0002",512,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",454,1,"Censored at the last contact date","ADVERSE EVENT"
"513","PSIVISSIG0002",513,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",323,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"514","PSIVISSIG0002",514,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"515","PSIVISSIG0002",515,51,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",105,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"516","PSIVISSIG0002",516,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"517","PSIVISSIG0002",517,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"518","PSIVISSIG0002",518,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",499,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"519","PSIVISSIG0002",519,58,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",971,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"520","PSIVISSIG0002",520,45,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1760,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"521","PSIVISSIG0002",521,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"522","PSIVISSIG0002",522,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",903,1,"Censored at the last contact date","SUBJECT/GUARDIAN DECISION"
"523","PSIVISSIG0002",523,19,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"524","PSIVISSIG0002",524,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"525","PSIVISSIG0002",525,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",734,1,"Censored at the last contact date","ADVERSE EVENT"
"526","PSIVISSIG0002",526,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",774,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"527","PSIVISSIG0002",527,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",18,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"528","PSIVISSIG0002",528,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",223,1,"Censored at the last contact date","ADVERSE EVENT"
"529","PSIVISSIG0002",529,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"530","PSIVISSIG0002",530,55,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1071,1,"Censored at the last contact date","ADVERSE EVENT"
"531","PSIVISSIG0002",531,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",457,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"532","PSIVISSIG0002",532,28,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"533","PSIVISSIG0002",533,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",16,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"534","PSIVISSIG0002",534,33,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"535","PSIVISSIG0002",535,46,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"536","PSIVISSIG0002",536,57,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",746,1,"Censored at the last contact date","ADVERSE EVENT"
"537","PSIVISSIG0002",537,58,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"538","PSIVISSIG0002",538,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1525,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"539","PSIVISSIG0002",539,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",492,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"540","PSIVISSIG0002",540,35,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",455,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"541","PSIVISSIG0002",541,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"542","PSIVISSIG0002",542,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"543","PSIVISSIG0002",543,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",93,1,"Censored at the last contact date","ADVERSE EVENT"
"544","PSIVISSIG0002",544,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",126,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"545","PSIVISSIG0002",545,34,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",15,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"546","PSIVISSIG0002",546,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",49,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"547","PSIVISSIG0002",547,51,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",868,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"548","PSIVISSIG0002",548,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",779,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"549","PSIVISSIG0002",549,41,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",962,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"550","PSIVISSIG0002",550,35,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1235,1,"Censored at the last contact date","ADVERSE EVENT"
"551","PSIVISSIG0002",551,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",544,1,"Censored at the last contact date","ADVERSE EVENT"
"552","PSIVISSIG0002",552,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"553","PSIVISSIG0002",553,38,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",543,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"554","PSIVISSIG0002",554,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"555","PSIVISSIG0002",555,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",857,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"556","PSIVISSIG0002",556,59,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",3,1,"Censored at the last contact date","ADVERSE EVENT"
"557","PSIVISSIG0002",557,38,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1310,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"558","PSIVISSIG0002",558,62,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",496,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"559","PSIVISSIG0002",559,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"560","PSIVISSIG0002",560,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",17,1,"Censored at the last contact date","ADVERSE EVENT"
"561","PSIVISSIG0002",561,40,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",922,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"562","PSIVISSIG0002",562,24,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"563","PSIVISSIG0002",563,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",463,1,"Censored at the last contact date","DEATH"
"564","PSIVISSIG0002",564,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",29,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"565","PSIVISSIG0002",565,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"566","PSIVISSIG0002",566,26,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",343,1,"Censored at the last contact date","ADVERSE EVENT"
"567","PSIVISSIG0002",567,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",733,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"568","PSIVISSIG0002",568,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"569","PSIVISSIG0002",569,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",244,1,"Censored at the last contact date","ADVERSE EVENT"
"570","PSIVISSIG0002",570,41,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",201,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"571","PSIVISSIG0002",571,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"572","PSIVISSIG0002",572,35,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",4,1,"Censored at the last contact date","ADVERSE EVENT"
"573","PSIVISSIG0002",573,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"574","PSIVISSIG0002",574,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",89,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"575","PSIVISSIG0002",575,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"576","PSIVISSIG0002",576,52,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",53,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"577","PSIVISSIG0002",577,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",126,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"578","PSIVISSIG0002",578,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",994,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"579","PSIVISSIG0002",579,55,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",492,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"580","PSIVISSIG0002",580,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",461,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"581","PSIVISSIG0002",581,55,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"582","PSIVISSIG0002",582,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",103,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"583","PSIVISSIG0002",583,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"584","PSIVISSIG0002",584,57,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",469,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"585","PSIVISSIG0002",585,42,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1051,1,"Censored at the last contact date","ADVERSE EVENT"
"586","PSIVISSIG0002",586,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1617,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"587","PSIVISSIG0002",587,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"588","PSIVISSIG0002",588,38,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",131,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"589","PSIVISSIG0002",589,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",392,1,"Censored at the last contact date","ADVERSE EVENT"
"590","PSIVISSIG0002",590,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",242,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"591","PSIVISSIG0002",591,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"592","PSIVISSIG0002",592,36,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",859,1,"Censored at the last contact date","ADVERSE EVENT"
"593","PSIVISSIG0002",593,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",412,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"594","PSIVISSIG0002",594,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1667,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"595","PSIVISSIG0002",595,33,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",168,1,"Censored at the last contact date","DEATH"
"596","PSIVISSIG0002",596,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"597","PSIVISSIG0002",597,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",414,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"598","PSIVISSIG0002",598,34,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",316,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"599","PSIVISSIG0002",599,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",958,1,"Censored at the last contact date","ADVERSE EVENT"
"600","PSIVISSIG0002",600,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"601","PSIVISSIG0002",601,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",803,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"602","PSIVISSIG0002",602,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",46,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"603","PSIVISSIG0002",603,43,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",955,1,"Censored at the last contact date","ADVERSE EVENT"
"604","PSIVISSIG0002",604,44,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",54,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"605","PSIVISSIG0002",605,32,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",338,1,"Censored at the last contact date","ADVERSE EVENT"
"606","PSIVISSIG0002",606,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1226,1,"Censored at the last contact date","ADVERSE EVENT"
"607","PSIVISSIG0002",607,41,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",719,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"608","PSIVISSIG0002",608,55,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",222,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"609","PSIVISSIG0002",609,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"610","PSIVISSIG0002",610,54,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"611","PSIVISSIG0002",611,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",380,1,"Censored at the last contact date","DEATH"
"612","PSIVISSIG0002",612,38,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1286,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"613","PSIVISSIG0002",613,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",175,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"614","PSIVISSIG0002",614,31,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1162,1,"Censored at the last contact date","ADVERSE EVENT"
"615","PSIVISSIG0002",615,66,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1221,1,"Censored at the last contact date","ADVERSE EVENT"
"616","PSIVISSIG0002",616,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",854,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"617","PSIVISSIG0002",617,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1343,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"618","PSIVISSIG0002",618,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"619","PSIVISSIG0002",619,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",799,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"620","PSIVISSIG0002",620,40,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",164,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"621","PSIVISSIG0002",621,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"622","PSIVISSIG0002",622,33,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",983,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"623","PSIVISSIG0002",623,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",646,1,"Censored at the last contact date","ADVERSE EVENT"
"624","PSIVISSIG0002",624,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",82,1,"Censored at the last contact date","ADVERSE EVENT"
"625","PSIVISSIG0002",625,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1668,1,"Censored at the last contact date","ADVERSE EVENT"
"626","PSIVISSIG0002",626,57,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",340,1,"Censored at the last contact date","ADVERSE EVENT"
"627","PSIVISSIG0002",627,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",261,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"628","PSIVISSIG0002",628,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",570,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"629","PSIVISSIG0002",629,56,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"630","PSIVISSIG0002",630,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",907,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"631","PSIVISSIG0002",631,57,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",6,1,"Censored at the last contact date","ADVERSE EVENT"
"632","PSIVISSIG0002",632,51,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"633","PSIVISSIG0002",633,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1532,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"634","PSIVISSIG0002",634,33,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"635","PSIVISSIG0002",635,43,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",377,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"636","PSIVISSIG0002",636,29,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",315,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"637","PSIVISSIG0002",637,25,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",686,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"638","PSIVISSIG0002",638,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",366,1,"Censored at the last contact date","ADVERSE EVENT"
"639","PSIVISSIG0002",639,29,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",10,1,"Censored at the last contact date","ADVERSE EVENT"
"640","PSIVISSIG0002",640,31,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",782,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"641","PSIVISSIG0002",641,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"642","PSIVISSIG0002",642,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",578,1,"Censored at the last contact date","DEATH"
"643","PSIVISSIG0002",643,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",298,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"644","PSIVISSIG0002",644,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",37,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"645","PSIVISSIG0002",645,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"646","PSIVISSIG0002",646,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",558,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"647","PSIVISSIG0002",647,43,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"648","PSIVISSIG0002",648,47,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"649","PSIVISSIG0002",649,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",388,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"650","PSIVISSIG0002",650,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1500,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"651","PSIVISSIG0002",651,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",967,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"652","PSIVISSIG0002",652,41,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",825,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"653","PSIVISSIG0002",653,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"654","PSIVISSIG0002",654,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1588,1,"Censored at the last contact date","ADVERSE EVENT"
"655","PSIVISSIG0002",655,41,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",989,1,"Censored at the last contact date","ADVERSE EVENT"
"656","PSIVISSIG0002",656,44,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1530,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"657","PSIVISSIG0002",657,61,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",987,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"658","PSIVISSIG0002",658,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1109,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"659","PSIVISSIG0002",659,34,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"660","PSIVISSIG0002",660,33,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1142,1,"Censored at the last contact date","ADVERSE EVENT"
"661","PSIVISSIG0002",661,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",96,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"662","PSIVISSIG0002",662,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1023,1,"Censored at the last contact date","ADVERSE EVENT"
"663","PSIVISSIG0002",663,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"664","PSIVISSIG0002",664,59,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",705,1,"Censored at the last contact date","ADVERSE EVENT"
"665","PSIVISSIG0002",665,20,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"666","PSIVISSIG0002",666,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"667","PSIVISSIG0002",667,28,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",122,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"668","PSIVISSIG0002",668,31,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"669","PSIVISSIG0002",669,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1293,1,"Censored at the last contact date","DEATH"
"670","PSIVISSIG0002",670,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",802,1,"Censored at the last contact date","DEATH"
"671","PSIVISSIG0002",671,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"672","PSIVISSIG0002",672,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"673","PSIVISSIG0002",673,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1647,1,"Censored at the last contact date","ADVERSE EVENT"
"674","PSIVISSIG0002",674,33,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"675","PSIVISSIG0002",675,55,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",203,1,"Censored at the last contact date","DEATH"
"676","PSIVISSIG0002",676,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",92,1,"Censored at the last contact date","ADVERSE EVENT"
"677","PSIVISSIG0002",677,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",50,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"678","PSIVISSIG0002",678,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"679","PSIVISSIG0002",679,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",123,1,"Censored at the last contact date","ADVERSE EVENT"
"680","PSIVISSIG0002",680,37,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",344,1,"Censored at the last contact date","ADVERSE EVENT"
"681","PSIVISSIG0002",681,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",45,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"682","PSIVISSIG0002",682,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"683","PSIVISSIG0002",683,48,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",967,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"684","PSIVISSIG0002",684,63,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1011,1,"Censored at the last contact date","ADVERSE EVENT"
"685","PSIVISSIG0002",685,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"686","PSIVISSIG0002",686,41,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1124,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"687","PSIVISSIG0002",687,27,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"688","PSIVISSIG0002",688,57,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",75,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"689","PSIVISSIG0002",689,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"690","PSIVISSIG0002",690,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1305,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"691","PSIVISSIG0002",691,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1072,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"692","PSIVISSIG0002",692,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1145,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"693","PSIVISSIG0002",693,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"694","PSIVISSIG0002",694,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1388,1,"Censored at the last contact date","ADVERSE EVENT"
"695","PSIVISSIG0002",695,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1640,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"696","PSIVISSIG0002",696,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",296,1,"Censored at the last contact date","DEATH"
"697","PSIVISSIG0002",697,23,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",234,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"698","PSIVISSIG0002",698,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1426,1,"Censored at the last contact date","ADVERSE EVENT"
"699","PSIVISSIG0002",699,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",310,1,"Censored at the last contact date","ADVERSE EVENT"
"700","PSIVISSIG0002",700,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",206,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"701","PSIVISSIG0002",701,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",242,1,"Censored at the last contact date","DEATH"
"702","PSIVISSIG0002",702,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",221,1,"Censored at the last contact date","ADVERSE EVENT"
"703","PSIVISSIG0002",703,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",479,1,"Censored at the last contact date","ADVERSE EVENT"
"704","PSIVISSIG0002",704,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1651,1,"Censored at the last contact date","ADVERSE EVENT"
"705","PSIVISSIG0002",705,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1541,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"706","PSIVISSIG0002",706,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1529,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"707","PSIVISSIG0002",707,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",468,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"708","PSIVISSIG0002",708,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",94,1,"Censored at the last contact date","ADVERSE EVENT"
"709","PSIVISSIG0002",709,27,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1461,1,"Censored at the last contact date","ADVERSE EVENT"
"710","PSIVISSIG0002",710,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",103,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"711","PSIVISSIG0002",711,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1452,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"712","PSIVISSIG0002",712,27,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",745,1,"Censored at the last contact date","ADVERSE EVENT"
"713","PSIVISSIG0002",713,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"714","PSIVISSIG0002",714,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"715","PSIVISSIG0002",715,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",443,1,"Censored at the last contact date","ADVERSE EVENT"
"716","PSIVISSIG0002",716,51,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"717","PSIVISSIG0002",717,25,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1228,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"718","PSIVISSIG0002",718,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",877,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"719","PSIVISSIG0002",719,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",481,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"720","PSIVISSIG0002",720,31,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"721","PSIVISSIG0002",721,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",502,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"722","PSIVISSIG0002",722,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",842,1,"Censored at the last contact date","ADVERSE EVENT"
"723","PSIVISSIG0002",723,43,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",0,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"724","PSIVISSIG0002",724,53,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",824,1,"Censored at the last contact date","ADVERSE EVENT"
"725","PSIVISSIG0002",725,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",499,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"726","PSIVISSIG0002",726,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"727","PSIVISSIG0002",727,30,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",131,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"728","PSIVISSIG0002",728,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1683,1,"Censored at the last contact date","ADVERSE EVENT"
"729","PSIVISSIG0002",729,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"730","PSIVISSIG0002",730,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"731","PSIVISSIG0002",731,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",305,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"732","PSIVISSIG0002",732,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",412,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"733","PSIVISSIG0002",733,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"734","PSIVISSIG0002",734,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"735","PSIVISSIG0002",735,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1256,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"736","PSIVISSIG0002",736,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"737","PSIVISSIG0002",737,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"738","PSIVISSIG0002",738,59,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",730,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"739","PSIVISSIG0002",739,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"740","PSIVISSIG0002",740,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"741","PSIVISSIG0002",741,56,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",380,1,"Censored at the last contact date","ADVERSE EVENT"
"742","PSIVISSIG0002",742,27,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",533,1,"Censored at the last contact date","ADVERSE EVENT"
"743","PSIVISSIG0002",743,33,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"744","PSIVISSIG0002",744,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"745","PSIVISSIG0002",745,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",654,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"746","PSIVISSIG0002",746,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",671,1,"Censored at the last contact date","ADVERSE EVENT"
"747","PSIVISSIG0002",747,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",390,1,"Censored at the last contact date","ADVERSE EVENT"
"748","PSIVISSIG0002",748,32,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",429,1,"Censored at the last contact date","ADVERSE EVENT"
"749","PSIVISSIG0002",749,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",449,1,"Censored at the last contact date","ADVERSE EVENT"
"750","PSIVISSIG0002",750,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",412,1,"Censored at the last contact date","DEATH"
"751","PSIVISSIG0002",751,46,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",375,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"752","PSIVISSIG0002",752,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",358,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"753","PSIVISSIG0002",753,41,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",168,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"754","PSIVISSIG0002",754,47,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",412,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"755","PSIVISSIG0002",755,46,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",10,1,"Censored at the last contact date","ADVERSE EVENT"
"756","PSIVISSIG0002",756,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"757","PSIVISSIG0002",757,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",126,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"758","PSIVISSIG0002",758,50,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1000,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"759","PSIVISSIG0002",759,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",931,1,"Censored at the last contact date","ADVERSE EVENT"
"760","PSIVISSIG0002",760,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",247,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"761","PSIVISSIG0002",761,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",240,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"762","PSIVISSIG0002",762,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"763","PSIVISSIG0002",763,45,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",255,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"764","PSIVISSIG0002",764,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"765","PSIVISSIG0002",765,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",751,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"766","PSIVISSIG0002",766,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"767","PSIVISSIG0002",767,51,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",314,1,"Censored at the last contact date","ADVERSE EVENT"
"768","PSIVISSIG0002",768,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",905,1,"Censored at the last contact date","ADVERSE EVENT"
"769","PSIVISSIG0002",769,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",809,1,"Censored at the last contact date","ADVERSE EVENT"
"770","PSIVISSIG0002",770,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",423,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"771","PSIVISSIG0002",771,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"772","PSIVISSIG0002",772,40,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",7,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"773","PSIVISSIG0002",773,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"774","PSIVISSIG0002",774,43,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",433,1,"Censored at the last contact date","ADVERSE EVENT"
"775","PSIVISSIG0002",775,23,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"776","PSIVISSIG0002",776,31,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"777","PSIVISSIG0002",777,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"778","PSIVISSIG0002",778,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",113,1,"Censored at the last contact date","ADVERSE EVENT"
"779","PSIVISSIG0002",779,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1438,1,"Censored at the last contact date","DEATH"
"780","PSIVISSIG0002",780,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",50,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"781","PSIVISSIG0002",781,39,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",203,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"782","PSIVISSIG0002",782,38,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"783","PSIVISSIG0002",783,28,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",754,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"784","PSIVISSIG0002",784,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",932,1,"Censored at the last contact date","ADVERSE EVENT"
"785","PSIVISSIG0002",785,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",946,1,"Censored at the last contact date","ADVERSE EVENT"
"786","PSIVISSIG0002",786,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1008,1,"Censored at the last contact date","ADVERSE EVENT"
"787","PSIVISSIG0002",787,37,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"788","PSIVISSIG0002",788,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"789","PSIVISSIG0002",789,57,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1434,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"790","PSIVISSIG0002",790,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1272,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"791","PSIVISSIG0002",791,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",224,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"792","PSIVISSIG0002",792,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"793","PSIVISSIG0002",793,32,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1176,1,"Censored at the last contact date","ADVERSE EVENT"
"794","PSIVISSIG0002",794,32,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"795","PSIVISSIG0002",795,28,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1542,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"796","PSIVISSIG0002",796,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"797","PSIVISSIG0002",797,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1696,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"798","PSIVISSIG0002",798,52,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",142,1,"Censored at the last contact date","ADVERSE EVENT"
"799","PSIVISSIG0002",799,58,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",388,1,"Censored at the last contact date","ADVERSE EVENT"
"800","PSIVISSIG0002",800,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",92,1,"Censored at the last contact date","ADVERSE EVENT"
"801","PSIVISSIG0002",801,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",2,1,"Censored at the last contact date","DEATH"
"802","PSIVISSIG0002",802,39,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",292,1,"Censored at the last contact date","ADVERSE EVENT"
"803","PSIVISSIG0002",803,36,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",982,1,"Censored at the last contact date","ADVERSE EVENT"
"804","PSIVISSIG0002",804,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"805","PSIVISSIG0002",805,41,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",197,1,"Censored at the last contact date","ADVERSE EVENT"
"806","PSIVISSIG0002",806,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1134,1,"Censored at the last contact date","ADVERSE EVENT"
"807","PSIVISSIG0002",807,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",242,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"808","PSIVISSIG0002",808,62,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"809","PSIVISSIG0002",809,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",837,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"810","PSIVISSIG0002",810,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1474,1,"Censored at the last contact date","ADVERSE EVENT"
"811","PSIVISSIG0002",811,59,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1278,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"812","PSIVISSIG0002",812,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",44,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"813","PSIVISSIG0002",813,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",757,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"814","PSIVISSIG0002",814,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",634,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"815","PSIVISSIG0002",815,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1596,1,"Censored at the last contact date","ADVERSE EVENT"
"816","PSIVISSIG0002",816,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",38,1,"Censored at the last contact date","ADVERSE EVENT"
"817","PSIVISSIG0002",817,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",749,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"818","PSIVISSIG0002",818,27,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",876,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"819","PSIVISSIG0002",819,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",85,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"820","PSIVISSIG0002",820,50,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",102,1,"Censored at the last contact date","ADVERSE EVENT"
"821","PSIVISSIG0002",821,31,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"822","PSIVISSIG0002",822,59,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1340,1,"Censored at the last contact date","ADVERSE EVENT"
"823","PSIVISSIG0002",823,36,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",156,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"824","PSIVISSIG0002",824,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",661,1,"Censored at the last contact date","ADVERSE EVENT"
"825","PSIVISSIG0002",825,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",327,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"826","PSIVISSIG0002",826,30,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",685,1,"Censored at the last contact date","ADVERSE EVENT"
"827","PSIVISSIG0002",827,57,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"828","PSIVISSIG0002",828,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1205,1,"Censored at the last contact date","ADVERSE EVENT"
"829","PSIVISSIG0002",829,55,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",373,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"830","PSIVISSIG0002",830,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",302,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"831","PSIVISSIG0002",831,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"832","PSIVISSIG0002",832,56,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1629,1,"Censored at the last contact date","ADVERSE EVENT"
"833","PSIVISSIG0002",833,53,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"834","PSIVISSIG0002",834,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"835","PSIVISSIG0002",835,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",911,1,"Censored at the last contact date","ADVERSE EVENT"
"836","PSIVISSIG0002",836,37,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",392,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"837","PSIVISSIG0002",837,33,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",180,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"838","PSIVISSIG0002",838,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",682,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"839","PSIVISSIG0002",839,51,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"840","PSIVISSIG0002",840,29,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",197,1,"Censored at the last contact date","ADVERSE EVENT"
"841","PSIVISSIG0002",841,56,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"842","PSIVISSIG0002",842,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",358,1,"Censored at the last contact date","ADVERSE EVENT"
"843","PSIVISSIG0002",843,60,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"844","PSIVISSIG0002",844,33,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",98,1,"Censored at the last contact date","ADVERSE EVENT"
"845","PSIVISSIG0002",845,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1368,1,"Censored at the last contact date","ADVERSE EVENT"
"846","PSIVISSIG0002",846,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",27,1,"Censored at the last contact date","ADVERSE EVENT"
"847","PSIVISSIG0002",847,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"848","PSIVISSIG0002",848,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",611,1,"Censored at the last contact date","ADVERSE EVENT"
"849","PSIVISSIG0002",849,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",732,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"850","PSIVISSIG0002",850,40,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",327,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"851","PSIVISSIG0002",851,25,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",586,1,"Censored at the last contact date","ADVERSE EVENT"
"852","PSIVISSIG0002",852,53,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1418,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"853","PSIVISSIG0002",853,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1145,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"854","PSIVISSIG0002",854,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",575,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"855","PSIVISSIG0002",855,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",144,1,"Censored at the last contact date","ADVERSE EVENT"
"856","PSIVISSIG0002",856,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1208,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"857","PSIVISSIG0002",857,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",271,1,"Censored at the last contact date","ADVERSE EVENT"
"858","PSIVISSIG0002",858,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",993,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"859","PSIVISSIG0002",859,68,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1617,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"860","PSIVISSIG0002",860,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"861","PSIVISSIG0002",861,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"862","PSIVISSIG0002",862,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",962,1,"Censored at the last contact date","ADVERSE EVENT"
"863","PSIVISSIG0002",863,46,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",551,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"864","PSIVISSIG0002",864,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",526,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"865","PSIVISSIG0002",865,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",166,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"866","PSIVISSIG0002",866,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",29,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"867","PSIVISSIG0002",867,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",662,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"868","PSIVISSIG0002",868,27,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",705,1,"Censored at the last contact date","DEATH"
"869","PSIVISSIG0002",869,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",110,1,"Censored at the last contact date","ADVERSE EVENT"
"870","PSIVISSIG0002",870,32,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"871","PSIVISSIG0002",871,30,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1353,1,"Censored at the last contact date","ADVERSE EVENT"
"872","PSIVISSIG0002",872,53,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1085,1,"Censored at the last contact date","ADVERSE EVENT"
"873","PSIVISSIG0002",873,26,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1264,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"874","PSIVISSIG0002",874,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",154,1,"Censored at the last contact date","ADVERSE EVENT"
"875","PSIVISSIG0002",875,55,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",314,1,"Censored at the last contact date","ADVERSE EVENT"
"876","PSIVISSIG0002",876,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1770,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"877","PSIVISSIG0002",877,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",293,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"878","PSIVISSIG0002",878,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",913,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"879","PSIVISSIG0002",879,27,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",242,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"880","PSIVISSIG0002",880,55,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1012,1,"Censored at the last contact date","ADVERSE EVENT"
"881","PSIVISSIG0002",881,51,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",528,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"882","PSIVISSIG0002",882,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",165,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"883","PSIVISSIG0002",883,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"884","PSIVISSIG0002",884,58,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"885","PSIVISSIG0002",885,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1530,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"886","PSIVISSIG0002",886,26,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"887","PSIVISSIG0002",887,31,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"888","PSIVISSIG0002",888,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",280,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"889","PSIVISSIG0002",889,49,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1316,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"890","PSIVISSIG0002",890,22,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1427,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"891","PSIVISSIG0002",891,43,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"892","PSIVISSIG0002",892,31,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",320,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"893","PSIVISSIG0002",893,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",788,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"894","PSIVISSIG0002",894,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",372,1,"Censored at the last contact date","DEATH"
"895","PSIVISSIG0002",895,50,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",676,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"896","PSIVISSIG0002",896,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1561,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"897","PSIVISSIG0002",897,35,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",110,1,"Censored at the last contact date","ADVERSE EVENT"
"898","PSIVISSIG0002",898,52,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",160,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"899","PSIVISSIG0002",899,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"900","PSIVISSIG0002",900,27,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",14,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"901","PSIVISSIG0002",901,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",218,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"902","PSIVISSIG0002",902,41,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",314,1,"Censored at the last contact date","ADVERSE EVENT"
"903","PSIVISSIG0002",903,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1232,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"904","PSIVISSIG0002",904,29,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",342,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"905","PSIVISSIG0002",905,35,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",446,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"906","PSIVISSIG0002",906,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1075,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"907","PSIVISSIG0002",907,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",957,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"908","PSIVISSIG0002",908,45,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",90,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"909","PSIVISSIG0002",909,29,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",44,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"910","PSIVISSIG0002",910,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",918,1,"Censored at the last contact date","ADVERSE EVENT"
"911","PSIVISSIG0002",911,41,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",38,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"912","PSIVISSIG0002",912,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1568,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"913","PSIVISSIG0002",913,43,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",91,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"914","PSIVISSIG0002",914,49,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",168,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"915","PSIVISSIG0002",915,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"916","PSIVISSIG0002",916,44,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",558,1,"Censored at the last contact date","ADVERSE EVENT"
"917","PSIVISSIG0002",917,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",662,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"918","PSIVISSIG0002",918,41,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1315,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"919","PSIVISSIG0002",919,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",23,1,"Censored at the last contact date","ADVERSE EVENT"
"920","PSIVISSIG0002",920,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",102,1,"Censored at the last contact date","ADVERSE EVENT"
"921","PSIVISSIG0002",921,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"922","PSIVISSIG0002",922,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",964,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"923","PSIVISSIG0002",923,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1331,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"924","PSIVISSIG0002",924,50,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1614,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"925","PSIVISSIG0002",925,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",841,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"926","PSIVISSIG0002",926,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",22,1,"Censored at the last contact date","ADVERSE EVENT"
"927","PSIVISSIG0002",927,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1186,1,"Censored at the last contact date","ADVERSE EVENT"
"928","PSIVISSIG0002",928,51,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",464,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"929","PSIVISSIG0002",929,40,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",82,1,"Censored at the last contact date","ADVERSE EVENT"
"930","PSIVISSIG0002",930,36,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",20,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"931","PSIVISSIG0002",931,55,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"932","PSIVISSIG0002",932,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1703,1,"Censored at the last contact date","DEATH"
"933","PSIVISSIG0002",933,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1185,1,"Censored at the last contact date","ADVERSE EVENT"
"934","PSIVISSIG0002",934,53,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1287,1,"Censored at the last contact date","ADVERSE EVENT"
"935","PSIVISSIG0002",935,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"936","PSIVISSIG0002",936,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1513,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"937","PSIVISSIG0002",937,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1712,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"938","PSIVISSIG0002",938,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"939","PSIVISSIG0002",939,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",306,1,"Censored at the last contact date","ADVERSE EVENT"
"940","PSIVISSIG0002",940,39,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",95,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"941","PSIVISSIG0002",941,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",911,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"942","PSIVISSIG0002",942,58,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1514,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"943","PSIVISSIG0002",943,51,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",784,1,"Censored at the last contact date","ADVERSE EVENT"
"944","PSIVISSIG0002",944,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",377,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"945","PSIVISSIG0002",945,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1015,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"946","PSIVISSIG0002",946,37,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",355,1,"Censored at the last contact date","ADVERSE EVENT"
"947","PSIVISSIG0002",947,38,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"948","PSIVISSIG0002",948,58,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",219,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"949","PSIVISSIG0002",949,53,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",761,1,"Censored at the last contact date","ADVERSE EVENT"
"950","PSIVISSIG0002",950,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",722,1,"Censored at the last contact date","ADVERSE EVENT"
"951","PSIVISSIG0002",951,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"952","PSIVISSIG0002",952,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",41,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"953","PSIVISSIG0002",953,31,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",671,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"954","PSIVISSIG0002",954,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1270,1,"Censored at the last contact date","ADVERSE EVENT"
"955","PSIVISSIG0002",955,55,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"956","PSIVISSIG0002",956,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",359,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"957","PSIVISSIG0002",957,46,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",347,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"958","PSIVISSIG0002",958,35,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",71,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"959","PSIVISSIG0002",959,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1482,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"960","PSIVISSIG0002",960,36,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",928,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"961","PSIVISSIG0002",961,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",266,1,"Censored at the last contact date","ADVERSE EVENT"
"962","PSIVISSIG0002",962,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",640,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"963","PSIVISSIG0002",963,43,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",938,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"964","PSIVISSIG0002",964,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"965","PSIVISSIG0002",965,39,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",875,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"966","PSIVISSIG0002",966,60,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1496,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"967","PSIVISSIG0002",967,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",613,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"968","PSIVISSIG0002",968,46,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",404,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"969","PSIVISSIG0002",969,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"970","PSIVISSIG0002",970,35,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"971","PSIVISSIG0002",971,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"972","PSIVISSIG0002",972,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"973","PSIVISSIG0002",973,46,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",944,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"974","PSIVISSIG0002",974,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1434,1,"Censored at the last contact date","ADVERSE EVENT"
"975","PSIVISSIG0002",975,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"976","PSIVISSIG0002",976,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",853,1,"Censored at the last contact date","DEATH"
"977","PSIVISSIG0002",977,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",456,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"978","PSIVISSIG0002",978,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1373,1,"Censored at the last contact date","ADVERSE EVENT"
"979","PSIVISSIG0002",979,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"980","PSIVISSIG0002",980,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",693,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"981","PSIVISSIG0002",981,44,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1032,1,"Censored at the last contact date","ADVERSE EVENT"
"982","PSIVISSIG0002",982,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",343,1,"Censored at the last contact date","ADVERSE EVENT"
"983","PSIVISSIG0002",983,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1117,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"984","PSIVISSIG0002",984,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"985","PSIVISSIG0002",985,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"986","PSIVISSIG0002",986,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",716,1,"Censored at the last contact date","DEATH"
"987","PSIVISSIG0002",987,44,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1162,1,"Censored at the last contact date","ADVERSE EVENT"
"988","PSIVISSIG0002",988,68,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",133,1,"Censored at the last contact date","ADVERSE EVENT"
"989","PSIVISSIG0002",989,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",737,1,"Censored at the last contact date","ADVERSE EVENT"
"990","PSIVISSIG0002",990,55,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1780,0,"NA",""
"991","PSIVISSIG0002",991,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",70,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"992","PSIVISSIG0002",992,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",867,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"993","PSIVISSIG0002",993,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",368,1,"Censored at the last contact date","ADVERSE EVENT"
"994","PSIVISSIG0002",994,27,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1378,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"995","PSIVISSIG0002",995,52,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",587,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"996","PSIVISSIG0002",996,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",352,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"997","PSIVISSIG0002",997,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1374,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"998","PSIVISSIG0002",998,43,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",26,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"999","PSIVISSIG0002",999,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",329,1,"Censored at the last contact date","ADVERSE EVENT"
"1000","PSIVISSIG0002",1000,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",1045,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1001","PSIVISSIG0002",1001,26,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1183,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1002","PSIVISSIG0002",1002,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",170,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1003","PSIVISSIG0002",1003,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",38,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1004","PSIVISSIG0002",1004,45,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab + vismab 52 weeks",4,"Progression-free survival (days)","PFS",761,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1005","PSIVISSIG0002",1005,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",517,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1006","PSIVISSIG0002",1006,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",9,1,"Censored at the last contact date","ADVERSE EVENT"
"1007","PSIVISSIG0002",1007,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1008","PSIVISSIG0002",1008,47,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",66,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1009","PSIVISSIG0002",1009,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",1438,1,"Censored at the last contact date","ADVERSE EVENT"
"1010","PSIVISSIG0002",1010,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",77,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1011","PSIVISSIG0002",1011,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",782,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1012","PSIVISSIG0002",1012,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","vismab x 52 weeks",2,"Progression-free survival (days)","PFS",918,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1013","PSIVISSIG0002",1,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",236,1,"Censored at the last contact date","ADVERSE EVENT"
"1014","PSIVISSIG0002",2,54,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1745,1,"Censored at the last contact date","ADVERSE EVENT"
"1015","PSIVISSIG0002",3,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1126,1,"Censored at the last contact date","ADVERSE EVENT"
"1016","PSIVISSIG0002",4,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",410,1,"Censored at the last contact date","ADVERSE EVENT"
"1017","PSIVISSIG0002",5,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1018","PSIVISSIG0002",6,55,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",671,1,"Censored at the last contact date","ADVERSE EVENT"
"1019","PSIVISSIG0002",7,37,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1331,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1020","PSIVISSIG0002",8,38,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1005,1,"Censored at the last contact date","ADVERSE EVENT"
"1021","PSIVISSIG0002",9,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",561,1,"Censored at the last contact date","ADVERSE EVENT"
"1022","PSIVISSIG0002",10,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1718,1,"Censored at the last contact date","DEATH"
"1023","PSIVISSIG0002",11,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",400,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1024","PSIVISSIG0002",12,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1635,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1025","PSIVISSIG0002",13,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",357,1,"Censored at the last contact date","ADVERSE EVENT"
"1026","PSIVISSIG0002",14,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",880,1,"Censored at the last contact date","ADVERSE EVENT"
"1027","PSIVISSIG0002",15,54,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",628,1,"Censored at the last contact date","ADVERSE EVENT"
"1028","PSIVISSIG0002",16,36,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1029","PSIVISSIG0002",17,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",692,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1030","PSIVISSIG0002",18,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1230,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1031","PSIVISSIG0002",19,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",417,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1032","PSIVISSIG0002",20,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",31,1,"Censored at the last contact date","ADVERSE EVENT"
"1033","PSIVISSIG0002",21,38,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1034","PSIVISSIG0002",22,27,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",263,1,"Censored at the last contact date","ADVERSE EVENT"
"1035","PSIVISSIG0002",23,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1036","PSIVISSIG0002",24,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",958,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1037","PSIVISSIG0002",25,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1038","PSIVISSIG0002",26,45,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",384,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1039","PSIVISSIG0002",27,38,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",505,1,"Censored at the last contact date","ADVERSE EVENT"
"1040","PSIVISSIG0002",28,46,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",906,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1041","PSIVISSIG0002",29,58,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",18,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1042","PSIVISSIG0002",30,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",70,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1043","PSIVISSIG0002",31,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",69,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1044","PSIVISSIG0002",32,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1045","PSIVISSIG0002",33,49,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",277,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1046","PSIVISSIG0002",34,38,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",866,1,"Censored at the last contact date","ADVERSE EVENT"
"1047","PSIVISSIG0002",35,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1048","PSIVISSIG0002",36,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1238,1,"Censored at the last contact date","ADVERSE EVENT"
"1049","PSIVISSIG0002",37,60,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",268,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1050","PSIVISSIG0002",38,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1051","PSIVISSIG0002",39,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1052","PSIVISSIG0002",40,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",556,1,"Censored at the last contact date","ADVERSE EVENT"
"1053","PSIVISSIG0002",41,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",238,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1054","PSIVISSIG0002",42,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",206,1,"Censored at the last contact date","ADVERSE EVENT"
"1055","PSIVISSIG0002",43,47,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1056","PSIVISSIG0002",44,26,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1174,1,"Censored at the last contact date","ADVERSE EVENT"
"1057","PSIVISSIG0002",45,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1178,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1058","PSIVISSIG0002",46,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",9,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1059","PSIVISSIG0002",47,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1060","PSIVISSIG0002",48,52,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1263,1,"Censored at the last contact date","ADVERSE EVENT"
"1061","PSIVISSIG0002",49,29,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",242,1,"Censored at the last contact date","ADVERSE EVENT"
"1062","PSIVISSIG0002",50,40,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",721,1,"Censored at the last contact date","ADVERSE EVENT"
"1063","PSIVISSIG0002",51,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1064","PSIVISSIG0002",52,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",169,1,"Censored at the last contact date","DEATH"
"1065","PSIVISSIG0002",53,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",792,1,"Censored at the last contact date","DEATH"
"1066","PSIVISSIG0002",54,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1338,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1067","PSIVISSIG0002",55,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1014,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1068","PSIVISSIG0002",56,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",385,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1069","PSIVISSIG0002",57,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1057,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1070","PSIVISSIG0002",58,39,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1071","PSIVISSIG0002",59,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1741,1,"Censored at the last contact date","DEATH"
"1072","PSIVISSIG0002",60,34,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",265,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1073","PSIVISSIG0002",61,32,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1074","PSIVISSIG0002",62,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",636,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1075","PSIVISSIG0002",63,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",123,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1076","PSIVISSIG0002",64,53,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1077","PSIVISSIG0002",65,29,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1078","PSIVISSIG0002",66,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1564,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1079","PSIVISSIG0002",67,37,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",376,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1080","PSIVISSIG0002",68,40,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1081","PSIVISSIG0002",69,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1082","PSIVISSIG0002",70,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",198,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1083","PSIVISSIG0002",71,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1550,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1084","PSIVISSIG0002",72,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1751,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1085","PSIVISSIG0002",73,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",906,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1086","PSIVISSIG0002",74,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",551,1,"Censored at the last contact date","ADVERSE EVENT"
"1087","PSIVISSIG0002",75,27,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1088","PSIVISSIG0002",76,56,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1089","PSIVISSIG0002",77,27,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1112,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1090","PSIVISSIG0002",78,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",12,1,"Censored at the last contact date","ADVERSE EVENT"
"1091","PSIVISSIG0002",79,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1092","PSIVISSIG0002",80,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1505,1,"Censored at the last contact date","DEATH"
"1093","PSIVISSIG0002",81,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",46,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1094","PSIVISSIG0002",82,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1457,1,"Censored at the last contact date","ADVERSE EVENT"
"1095","PSIVISSIG0002",83,36,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",371,1,"Censored at the last contact date","ADVERSE EVENT"
"1096","PSIVISSIG0002",84,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1097","PSIVISSIG0002",85,28,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1342,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1098","PSIVISSIG0002",86,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",431,1,"Censored at the last contact date","ADVERSE EVENT"
"1099","PSIVISSIG0002",87,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",486,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1100","PSIVISSIG0002",88,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1568,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1101","PSIVISSIG0002",89,31,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",493,1,"Censored at the last contact date","ADVERSE EVENT"
"1102","PSIVISSIG0002",90,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1593,1,"Censored at the last contact date","ADVERSE EVENT"
"1103","PSIVISSIG0002",91,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1104","PSIVISSIG0002",92,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",114,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1105","PSIVISSIG0002",93,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",812,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1106","PSIVISSIG0002",94,38,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1107","PSIVISSIG0002",95,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",328,1,"Censored at the last contact date","ADVERSE EVENT"
"1108","PSIVISSIG0002",96,53,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1109","PSIVISSIG0002",97,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",116,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1110","PSIVISSIG0002",98,47,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",82,1,"Censored at the last contact date","DEATH"
"1111","PSIVISSIG0002",99,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1087,1,"Censored at the last contact date","ADVERSE EVENT"
"1112","PSIVISSIG0002",100,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",699,1,"Censored at the last contact date","DEATH"
"1113","PSIVISSIG0002",101,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",193,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1114","PSIVISSIG0002",102,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",27,1,"Censored at the last contact date","ADVERSE EVENT"
"1115","PSIVISSIG0002",103,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",563,1,"Censored at the last contact date","ADVERSE EVENT"
"1116","PSIVISSIG0002",104,56,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1117","PSIVISSIG0002",105,47,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",39,1,"Censored at the last contact date","ADVERSE EVENT"
"1118","PSIVISSIG0002",106,29,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",334,1,"Censored at the last contact date","ADVERSE EVENT"
"1119","PSIVISSIG0002",107,28,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1120","PSIVISSIG0002",108,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",13,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1121","PSIVISSIG0002",109,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1122","PSIVISSIG0002",110,49,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",84,1,"Censored at the last contact date","ADVERSE EVENT"
"1123","PSIVISSIG0002",111,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1124","PSIVISSIG0002",112,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",45,1,"Censored at the last contact date","DEATH"
"1125","PSIVISSIG0002",113,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",42,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1126","PSIVISSIG0002",114,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1127","PSIVISSIG0002",115,44,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",85,1,"Censored at the last contact date","ADVERSE EVENT"
"1128","PSIVISSIG0002",116,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",927,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1129","PSIVISSIG0002",117,54,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1328,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1130","PSIVISSIG0002",118,29,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1223,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1131","PSIVISSIG0002",119,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1210,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1132","PSIVISSIG0002",120,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",178,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1133","PSIVISSIG0002",121,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",646,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1134","PSIVISSIG0002",122,42,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1445,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1135","PSIVISSIG0002",123,37,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1136","PSIVISSIG0002",124,35,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1016,1,"Censored at the last contact date","ADVERSE EVENT"
"1137","PSIVISSIG0002",125,30,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",422,1,"Censored at the last contact date","ADVERSE EVENT"
"1138","PSIVISSIG0002",126,35,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",308,1,"Censored at the last contact date","ADVERSE EVENT"
"1139","PSIVISSIG0002",127,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1140","PSIVISSIG0002",128,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1141","PSIVISSIG0002",129,58,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",773,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1142","PSIVISSIG0002",130,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1566,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1143","PSIVISSIG0002",131,66,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",457,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1144","PSIVISSIG0002",132,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1349,1,"Censored at the last contact date","ADVERSE EVENT"
"1145","PSIVISSIG0002",133,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1729,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1146","PSIVISSIG0002",134,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1147","PSIVISSIG0002",135,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1314,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1148","PSIVISSIG0002",136,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",169,1,"Censored at the last contact date","DEATH"
"1149","PSIVISSIG0002",137,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",575,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1150","PSIVISSIG0002",138,45,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",72,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1151","PSIVISSIG0002",139,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1054,1,"Censored at the last contact date","ADVERSE EVENT"
"1152","PSIVISSIG0002",140,60,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",45,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1153","PSIVISSIG0002",141,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1282,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1154","PSIVISSIG0002",142,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",300,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1155","PSIVISSIG0002",143,37,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",574,1,"Censored at the last contact date","ADVERSE EVENT"
"1156","PSIVISSIG0002",144,42,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",282,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1157","PSIVISSIG0002",145,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1158","PSIVISSIG0002",146,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1159","PSIVISSIG0002",147,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",327,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1160","PSIVISSIG0002",148,46,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",246,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1161","PSIVISSIG0002",149,47,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1069,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1162","PSIVISSIG0002",150,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",80,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1163","PSIVISSIG0002",151,45,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",69,1,"Censored at the last contact date","ADVERSE EVENT"
"1164","PSIVISSIG0002",152,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1225,1,"Censored at the last contact date","ADVERSE EVENT"
"1165","PSIVISSIG0002",153,56,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",858,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1166","PSIVISSIG0002",154,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",592,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1167","PSIVISSIG0002",155,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1168","PSIVISSIG0002",156,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1169","PSIVISSIG0002",157,38,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1170","PSIVISSIG0002",158,55,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1171","PSIVISSIG0002",159,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",612,1,"Censored at the last contact date","ADVERSE EVENT"
"1172","PSIVISSIG0002",160,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1323,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1173","PSIVISSIG0002",161,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",660,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1174","PSIVISSIG0002",162,56,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",149,1,"Censored at the last contact date","ADVERSE EVENT"
"1175","PSIVISSIG0002",163,54,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1000,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1176","PSIVISSIG0002",164,46,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1177","PSIVISSIG0002",165,27,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",914,1,"Censored at the last contact date","ADVERSE EVENT"
"1178","PSIVISSIG0002",166,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",999,1,"Censored at the last contact date","ADVERSE EVENT"
"1179","PSIVISSIG0002",167,49,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1013,1,"Censored at the last contact date","ADVERSE EVENT"
"1180","PSIVISSIG0002",168,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",278,1,"Censored at the last contact date","ADVERSE EVENT"
"1181","PSIVISSIG0002",169,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",660,1,"Censored at the last contact date","ADVERSE EVENT"
"1182","PSIVISSIG0002",170,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1132,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1183","PSIVISSIG0002",171,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",917,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1184","PSIVISSIG0002",172,28,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",646,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1185","PSIVISSIG0002",173,27,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1186","PSIVISSIG0002",174,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",330,1,"Censored at the last contact date","DEATH"
"1187","PSIVISSIG0002",175,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1154,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1188","PSIVISSIG0002",176,46,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1189","PSIVISSIG0002",177,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",309,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1190","PSIVISSIG0002",178,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1191","PSIVISSIG0002",179,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1192","PSIVISSIG0002",180,47,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",261,1,"Censored at the last contact date","ADVERSE EVENT"
"1193","PSIVISSIG0002",181,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",79,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1194","PSIVISSIG0002",182,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",88,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1195","PSIVISSIG0002",183,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1196","PSIVISSIG0002",184,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",383,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1197","PSIVISSIG0002",185,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1708,1,"Censored at the last contact date","ADVERSE EVENT"
"1198","PSIVISSIG0002",186,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1199","PSIVISSIG0002",187,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1271,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1200","PSIVISSIG0002",188,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1162,1,"Censored at the last contact date","ADVERSE EVENT"
"1201","PSIVISSIG0002",189,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",875,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1202","PSIVISSIG0002",190,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1203","PSIVISSIG0002",191,35,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1410,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1204","PSIVISSIG0002",192,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",512,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1205","PSIVISSIG0002",193,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",393,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1206","PSIVISSIG0002",194,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1622,1,"Censored at the last contact date","ADVERSE EVENT"
"1207","PSIVISSIG0002",195,60,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",493,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1208","PSIVISSIG0002",196,51,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",892,1,"Censored at the last contact date","ADVERSE EVENT"
"1209","PSIVISSIG0002",197,29,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1210","PSIVISSIG0002",198,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",314,1,"Censored at the last contact date","ADVERSE EVENT"
"1211","PSIVISSIG0002",199,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",693,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1212","PSIVISSIG0002",200,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1213","PSIVISSIG0002",201,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",18,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1214","PSIVISSIG0002",202,53,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1215","PSIVISSIG0002",203,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",43,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1216","PSIVISSIG0002",204,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1581,1,"Censored at the last contact date","DEATH"
"1217","PSIVISSIG0002",205,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1378,1,"Censored at the last contact date","ADVERSE EVENT"
"1218","PSIVISSIG0002",206,33,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",188,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1219","PSIVISSIG0002",207,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1002,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1220","PSIVISSIG0002",208,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",445,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1221","PSIVISSIG0002",209,49,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",107,1,"Censored at the last contact date","ADVERSE EVENT"
"1222","PSIVISSIG0002",210,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",360,1,"Censored at the last contact date","ADVERSE EVENT"
"1223","PSIVISSIG0002",211,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1224","PSIVISSIG0002",212,36,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",835,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1225","PSIVISSIG0002",213,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",25,1,"Censored at the last contact date","ADVERSE EVENT"
"1226","PSIVISSIG0002",214,53,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",275,1,"Censored at the last contact date","ADVERSE EVENT"
"1227","PSIVISSIG0002",215,55,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1225,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1228","PSIVISSIG0002",216,29,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1229","PSIVISSIG0002",217,58,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1230","PSIVISSIG0002",218,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1272,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1231","PSIVISSIG0002",219,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",48,1,"Censored at the last contact date","ADVERSE EVENT"
"1232","PSIVISSIG0002",220,43,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",446,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1233","PSIVISSIG0002",221,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1739,1,"Censored at the last contact date","ADVERSE EVENT"
"1234","PSIVISSIG0002",222,42,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",554,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1235","PSIVISSIG0002",223,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1236","PSIVISSIG0002",224,29,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1237","PSIVISSIG0002",225,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",648,1,"Censored at the last contact date","ADVERSE EVENT"
"1238","PSIVISSIG0002",226,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1239","PSIVISSIG0002",227,27,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1240","PSIVISSIG0002",228,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",2,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1241","PSIVISSIG0002",229,31,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1663,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1242","PSIVISSIG0002",230,36,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1351,1,"Censored at the last contact date","ADVERSE EVENT"
"1243","PSIVISSIG0002",231,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1244","PSIVISSIG0002",232,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",517,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1245","PSIVISSIG0002",233,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1246","PSIVISSIG0002",234,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",260,1,"Censored at the last contact date","DEATH"
"1247","PSIVISSIG0002",235,58,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1248","PSIVISSIG0002",236,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1249","PSIVISSIG0002",237,56,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1182,1,"Censored at the last contact date","ADVERSE EVENT"
"1250","PSIVISSIG0002",238,44,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",275,1,"Censored at the last contact date","ADVERSE EVENT"
"1251","PSIVISSIG0002",239,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",321,1,"Censored at the last contact date","ADVERSE EVENT"
"1252","PSIVISSIG0002",240,50,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1383,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1253","PSIVISSIG0002",241,48,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",559,1,"Censored at the last contact date","ADVERSE EVENT"
"1254","PSIVISSIG0002",242,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",162,1,"Censored at the last contact date","ADVERSE EVENT"
"1255","PSIVISSIG0002",243,31,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1256","PSIVISSIG0002",244,33,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1295,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1257","PSIVISSIG0002",245,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",180,1,"Censored at the last contact date","ADVERSE EVENT"
"1258","PSIVISSIG0002",246,51,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1479,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1259","PSIVISSIG0002",247,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1110,1,"Censored at the last contact date","DEATH"
"1260","PSIVISSIG0002",248,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",269,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1261","PSIVISSIG0002",249,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",32,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1262","PSIVISSIG0002",250,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1309,1,"Censored at the last contact date","ADVERSE EVENT"
"1263","PSIVISSIG0002",251,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",135,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1264","PSIVISSIG0002",252,50,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",497,1,"Censored at the last contact date","ADVERSE EVENT"
"1265","PSIVISSIG0002",253,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",530,1,"Censored at the last contact date","ADVERSE EVENT"
"1266","PSIVISSIG0002",254,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1267","PSIVISSIG0002",255,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1268","PSIVISSIG0002",256,59,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",707,1,"Censored at the last contact date","ADVERSE EVENT"
"1269","PSIVISSIG0002",257,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1759,1,"Censored at the last contact date","ADVERSE EVENT"
"1270","PSIVISSIG0002",258,57,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",306,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1271","PSIVISSIG0002",259,41,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",322,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1272","PSIVISSIG0002",260,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",591,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1273","PSIVISSIG0002",261,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1482,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1274","PSIVISSIG0002",262,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1768,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1275","PSIVISSIG0002",263,33,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",556,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1276","PSIVISSIG0002",264,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1663,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1277","PSIVISSIG0002",265,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1077,1,"Censored at the last contact date","ADVERSE EVENT"
"1278","PSIVISSIG0002",266,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1079,1,"Censored at the last contact date","ADVERSE EVENT"
"1279","PSIVISSIG0002",267,55,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1065,1,"Censored at the last contact date","ADVERSE EVENT"
"1280","PSIVISSIG0002",268,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",148,1,"Censored at the last contact date","ADVERSE EVENT"
"1281","PSIVISSIG0002",269,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",562,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1282","PSIVISSIG0002",270,54,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",58,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1283","PSIVISSIG0002",271,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",500,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1284","PSIVISSIG0002",272,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1285","PSIVISSIG0002",273,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",139,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1286","PSIVISSIG0002",274,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1287","PSIVISSIG0002",275,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1288","PSIVISSIG0002",276,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",484,1,"Censored at the last contact date","ADVERSE EVENT"
"1289","PSIVISSIG0002",277,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1290","PSIVISSIG0002",278,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1291","PSIVISSIG0002",279,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",993,1,"Censored at the last contact date","ADVERSE EVENT"
"1292","PSIVISSIG0002",280,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",146,1,"Censored at the last contact date","DEATH"
"1293","PSIVISSIG0002",281,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1294","PSIVISSIG0002",282,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1174,1,"Censored at the last contact date","ADVERSE EVENT"
"1295","PSIVISSIG0002",283,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1296","PSIVISSIG0002",284,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",8,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1297","PSIVISSIG0002",285,53,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1298","PSIVISSIG0002",286,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1299","PSIVISSIG0002",287,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1300","PSIVISSIG0002",288,32,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",701,1,"Censored at the last contact date","ADVERSE EVENT"
"1301","PSIVISSIG0002",289,39,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1239,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1302","PSIVISSIG0002",290,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1459,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1303","PSIVISSIG0002",291,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1084,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1304","PSIVISSIG0002",292,36,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",327,1,"Censored at the last contact date","ADVERSE EVENT"
"1305","PSIVISSIG0002",293,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",196,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1306","PSIVISSIG0002",294,43,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",448,1,"Censored at the last contact date","ADVERSE EVENT"
"1307","PSIVISSIG0002",295,45,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",543,1,"Censored at the last contact date","ADVERSE EVENT"
"1308","PSIVISSIG0002",296,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1309","PSIVISSIG0002",297,39,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",827,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1310","PSIVISSIG0002",298,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1228,1,"Censored at the last contact date","ADVERSE EVENT"
"1311","PSIVISSIG0002",299,43,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",48,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1312","PSIVISSIG0002",300,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",825,1,"Censored at the last contact date","ADVERSE EVENT"
"1313","PSIVISSIG0002",301,20,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",875,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1314","PSIVISSIG0002",302,40,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",200,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1315","PSIVISSIG0002",303,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",241,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1316","PSIVISSIG0002",304,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",966,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1317","PSIVISSIG0002",305,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",314,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1318","PSIVISSIG0002",306,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1067,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1319","PSIVISSIG0002",307,38,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1511,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1320","PSIVISSIG0002",308,33,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1668,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1321","PSIVISSIG0002",309,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1322","PSIVISSIG0002",310,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",685,1,"Censored at the last contact date","ADVERSE EVENT"
"1323","PSIVISSIG0002",311,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1324","PSIVISSIG0002",312,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",107,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1325","PSIVISSIG0002",313,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",448,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1326","PSIVISSIG0002",314,64,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",292,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1327","PSIVISSIG0002",315,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1328","PSIVISSIG0002",316,33,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1697,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1329","PSIVISSIG0002",317,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1479,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1330","PSIVISSIG0002",318,53,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1474,1,"Censored at the last contact date","ADVERSE EVENT"
"1331","PSIVISSIG0002",319,41,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",116,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1332","PSIVISSIG0002",320,30,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1319,1,"Censored at the last contact date","ADVERSE EVENT"
"1333","PSIVISSIG0002",321,35,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1334","PSIVISSIG0002",322,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1195,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1335","PSIVISSIG0002",323,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",313,1,"Censored at the last contact date","ADVERSE EVENT"
"1336","PSIVISSIG0002",324,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",968,1,"Censored at the last contact date","ADVERSE EVENT"
"1337","PSIVISSIG0002",325,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1338","PSIVISSIG0002",326,41,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1558,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1339","PSIVISSIG0002",327,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",181,1,"Censored at the last contact date","ADVERSE EVENT"
"1340","PSIVISSIG0002",328,28,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",830,1,"Censored at the last contact date","ADVERSE EVENT"
"1341","PSIVISSIG0002",329,57,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1035,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1342","PSIVISSIG0002",330,54,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",393,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1343","PSIVISSIG0002",331,29,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",806,1,"Censored at the last contact date","ADVERSE EVENT"
"1344","PSIVISSIG0002",332,24,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1518,1,"Censored at the last contact date","ADVERSE EVENT"
"1345","PSIVISSIG0002",333,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",101,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1346","PSIVISSIG0002",334,35,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1347","PSIVISSIG0002",335,52,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",426,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1348","PSIVISSIG0002",336,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",34,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1349","PSIVISSIG0002",337,29,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",195,1,"Censored at the last contact date","ADVERSE EVENT"
"1350","PSIVISSIG0002",338,29,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1682,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1351","PSIVISSIG0002",339,34,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",346,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1352","PSIVISSIG0002",340,43,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1762,1,"Censored at the last contact date","ADVERSE EVENT"
"1353","PSIVISSIG0002",341,58,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",842,1,"Censored at the last contact date","ADVERSE EVENT"
"1354","PSIVISSIG0002",342,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",329,1,"Censored at the last contact date","ADVERSE EVENT"
"1355","PSIVISSIG0002",343,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1356","PSIVISSIG0002",344,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",898,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1357","PSIVISSIG0002",345,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1358","PSIVISSIG0002",346,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",500,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1359","PSIVISSIG0002",347,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",160,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1360","PSIVISSIG0002",348,44,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",176,1,"Censored at the last contact date","ADVERSE EVENT"
"1361","PSIVISSIG0002",349,61,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",954,1,"Censored at the last contact date","ADVERSE EVENT"
"1362","PSIVISSIG0002",350,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",579,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1363","PSIVISSIG0002",351,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1666,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1364","PSIVISSIG0002",352,34,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",890,1,"Censored at the last contact date","ADVERSE EVENT"
"1365","PSIVISSIG0002",353,33,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",230,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1366","PSIVISSIG0002",354,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",526,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1367","PSIVISSIG0002",355,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",747,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1368","PSIVISSIG0002",356,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",994,1,"Censored at the last contact date","ADVERSE EVENT"
"1369","PSIVISSIG0002",357,41,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",260,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1370","PSIVISSIG0002",358,41,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",392,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1371","PSIVISSIG0002",359,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",461,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1372","PSIVISSIG0002",360,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",13,1,"Censored at the last contact date","ADVERSE EVENT"
"1373","PSIVISSIG0002",361,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1374","PSIVISSIG0002",362,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",858,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1375","PSIVISSIG0002",363,51,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1376","PSIVISSIG0002",364,38,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",670,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1377","PSIVISSIG0002",365,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",31,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1378","PSIVISSIG0002",366,61,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",283,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1379","PSIVISSIG0002",367,54,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1001,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1380","PSIVISSIG0002",368,40,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1381","PSIVISSIG0002",369,45,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",343,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1382","PSIVISSIG0002",370,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1115,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1383","PSIVISSIG0002",371,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1017,1,"Censored at the last contact date","ADVERSE EVENT"
"1384","PSIVISSIG0002",372,30,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",293,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1385","PSIVISSIG0002",373,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1386","PSIVISSIG0002",374,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",945,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1387","PSIVISSIG0002",375,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1388","PSIVISSIG0002",376,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",2,1,"Censored at the last contact date","ADVERSE EVENT"
"1389","PSIVISSIG0002",377,58,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",675,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1390","PSIVISSIG0002",378,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",271,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1391","PSIVISSIG0002",379,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",161,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1392","PSIVISSIG0002",380,36,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",56,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1393","PSIVISSIG0002",381,51,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1003,1,"Censored at the last contact date","ADVERSE EVENT"
"1394","PSIVISSIG0002",382,55,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1415,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1395","PSIVISSIG0002",383,57,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",177,1,"Censored at the last contact date","ADVERSE EVENT"
"1396","PSIVISSIG0002",384,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",119,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1397","PSIVISSIG0002",385,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",108,1,"Censored at the last contact date","ADVERSE EVENT"
"1398","PSIVISSIG0002",386,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",905,1,"Censored at the last contact date","ADVERSE EVENT"
"1399","PSIVISSIG0002",387,33,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1350,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1400","PSIVISSIG0002",388,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1636,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1401","PSIVISSIG0002",389,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",178,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1402","PSIVISSIG0002",390,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",74,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1403","PSIVISSIG0002",391,60,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",899,1,"Censored at the last contact date","ADVERSE EVENT"
"1404","PSIVISSIG0002",392,35,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",382,1,"Censored at the last contact date","ADVERSE EVENT"
"1405","PSIVISSIG0002",393,31,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",109,1,"Censored at the last contact date","ADVERSE EVENT"
"1406","PSIVISSIG0002",394,44,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",406,1,"Censored at the last contact date","DEATH"
"1407","PSIVISSIG0002",395,31,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",75,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1408","PSIVISSIG0002",396,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",539,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1409","PSIVISSIG0002",397,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",93,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1410","PSIVISSIG0002",398,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",158,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1411","PSIVISSIG0002",399,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1412","PSIVISSIG0002",400,28,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",830,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1413","PSIVISSIG0002",401,38,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",83,1,"Censored at the last contact date","ADVERSE EVENT"
"1414","PSIVISSIG0002",402,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",232,1,"Censored at the last contact date","ADVERSE EVENT"
"1415","PSIVISSIG0002",403,55,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",366,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1416","PSIVISSIG0002",404,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1257,1,"Censored at the last contact date","ADVERSE EVENT"
"1417","PSIVISSIG0002",405,32,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",795,1,"Censored at the last contact date","ADVERSE EVENT"
"1418","PSIVISSIG0002",406,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",533,1,"Censored at the last contact date","ADVERSE EVENT"
"1419","PSIVISSIG0002",407,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",782,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1420","PSIVISSIG0002",408,54,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1214,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1421","PSIVISSIG0002",409,57,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1422","PSIVISSIG0002",410,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",254,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1423","PSIVISSIG0002",411,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",490,1,"Censored at the last contact date","ADVERSE EVENT"
"1424","PSIVISSIG0002",412,69,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",184,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1425","PSIVISSIG0002",413,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1426","PSIVISSIG0002",414,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",760,1,"Censored at the last contact date","DEATH"
"1427","PSIVISSIG0002",415,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1428","PSIVISSIG0002",416,53,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",773,1,"Censored at the last contact date","DEATH"
"1429","PSIVISSIG0002",417,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1430","PSIVISSIG0002",418,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1431","PSIVISSIG0002",419,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1065,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1432","PSIVISSIG0002",420,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",44,1,"Censored at the last contact date","ADVERSE EVENT"
"1433","PSIVISSIG0002",421,41,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1434","PSIVISSIG0002",422,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1435","PSIVISSIG0002",423,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",142,1,"Censored at the last contact date","DEATH"
"1436","PSIVISSIG0002",424,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1728,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1437","PSIVISSIG0002",425,56,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",56,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1438","PSIVISSIG0002",426,51,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",115,1,"Censored at the last contact date","ADVERSE EVENT"
"1439","PSIVISSIG0002",427,45,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",163,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1440","PSIVISSIG0002",428,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1294,1,"Censored at the last contact date","ADVERSE EVENT"
"1441","PSIVISSIG0002",429,57,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",659,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1442","PSIVISSIG0002",430,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",96,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1443","PSIVISSIG0002",431,37,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1444","PSIVISSIG0002",432,41,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",18,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1445","PSIVISSIG0002",433,37,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",357,1,"Censored at the last contact date","ADVERSE EVENT"
"1446","PSIVISSIG0002",434,34,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1535,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1447","PSIVISSIG0002",435,43,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",152,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1448","PSIVISSIG0002",436,77,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",90,1,"Censored at the last contact date","ADVERSE EVENT"
"1449","PSIVISSIG0002",437,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",827,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1450","PSIVISSIG0002",438,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1451","PSIVISSIG0002",439,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",281,1,"Censored at the last contact date","ADVERSE EVENT"
"1452","PSIVISSIG0002",440,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1453","PSIVISSIG0002",441,26,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",64,1,"Censored at the last contact date","ADVERSE EVENT"
"1454","PSIVISSIG0002",442,31,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",14,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1455","PSIVISSIG0002",443,51,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",927,1,"Censored at the last contact date","ADVERSE EVENT"
"1456","PSIVISSIG0002",444,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1457","PSIVISSIG0002",445,40,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",351,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1458","PSIVISSIG0002",446,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",437,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1459","PSIVISSIG0002",447,53,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",498,1,"Censored at the last contact date","DEATH"
"1460","PSIVISSIG0002",448,38,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",239,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1461","PSIVISSIG0002",449,35,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",749,1,"Censored at the last contact date","ADVERSE EVENT"
"1462","PSIVISSIG0002",450,36,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",331,1,"Censored at the last contact date","DEATH"
"1463","PSIVISSIG0002",451,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",421,1,"Censored at the last contact date","ADVERSE EVENT"
"1464","PSIVISSIG0002",452,32,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1465","PSIVISSIG0002",453,49,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",960,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1466","PSIVISSIG0002",454,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",28,1,"Censored at the last contact date","ADVERSE EVENT"
"1467","PSIVISSIG0002",455,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",412,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1468","PSIVISSIG0002",456,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1469","PSIVISSIG0002",457,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",831,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1470","PSIVISSIG0002",458,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1471","PSIVISSIG0002",459,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",606,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1472","PSIVISSIG0002",460,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",982,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1473","PSIVISSIG0002",461,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",859,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1474","PSIVISSIG0002",462,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",12,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1475","PSIVISSIG0002",463,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",807,1,"Censored at the last contact date","ADVERSE EVENT"
"1476","PSIVISSIG0002",464,34,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1043,1,"Censored at the last contact date","DEATH"
"1477","PSIVISSIG0002",465,61,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1371,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1478","PSIVISSIG0002",466,57,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",372,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1479","PSIVISSIG0002",467,40,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",52,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1480","PSIVISSIG0002",468,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",496,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1481","PSIVISSIG0002",469,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",446,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1482","PSIVISSIG0002",470,40,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",708,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1483","PSIVISSIG0002",471,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",741,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1484","PSIVISSIG0002",472,36,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",47,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1485","PSIVISSIG0002",473,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",127,1,"Censored at the last contact date","ADVERSE EVENT"
"1486","PSIVISSIG0002",474,48,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",335,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1487","PSIVISSIG0002",475,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",919,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1488","PSIVISSIG0002",476,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",633,1,"Censored at the last contact date","DEATH"
"1489","PSIVISSIG0002",477,23,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1490","PSIVISSIG0002",478,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1162,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1491","PSIVISSIG0002",479,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",801,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1492","PSIVISSIG0002",480,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",847,1,"Censored at the last contact date","ADVERSE EVENT"
"1493","PSIVISSIG0002",481,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",166,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1494","PSIVISSIG0002",482,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1495","PSIVISSIG0002",483,36,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",761,1,"Censored at the last contact date","ADVERSE EVENT"
"1496","PSIVISSIG0002",484,58,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1676,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1497","PSIVISSIG0002",485,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",154,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1498","PSIVISSIG0002",486,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1499","PSIVISSIG0002",487,53,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",464,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1500","PSIVISSIG0002",488,38,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",786,1,"Censored at the last contact date","ADVERSE EVENT"
"1501","PSIVISSIG0002",489,56,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",330,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1502","PSIVISSIG0002",490,53,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1051,1,"Censored at the last contact date","ADVERSE EVENT"
"1503","PSIVISSIG0002",491,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",397,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1504","PSIVISSIG0002",492,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",93,1,"Censored at the last contact date","ADVERSE EVENT"
"1505","PSIVISSIG0002",493,54,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",427,1,"Censored at the last contact date","ADVERSE EVENT"
"1506","PSIVISSIG0002",494,57,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",114,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1507","PSIVISSIG0002",495,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1448,1,"Censored at the last contact date","ADVERSE EVENT"
"1508","PSIVISSIG0002",496,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1195,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1509","PSIVISSIG0002",497,55,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",34,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1510","PSIVISSIG0002",498,61,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",178,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1511","PSIVISSIG0002",499,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1626,1,"Censored at the last contact date","DEATH"
"1512","PSIVISSIG0002",500,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",964,1,"Censored at the last contact date","ADVERSE EVENT"
"1513","PSIVISSIG0002",501,23,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1514","PSIVISSIG0002",502,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",91,1,"Censored at the last contact date","ADVERSE EVENT"
"1515","PSIVISSIG0002",503,33,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1441,1,"Censored at the last contact date","DEATH"
"1516","PSIVISSIG0002",504,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",502,1,"Censored at the last contact date","ADVERSE EVENT"
"1517","PSIVISSIG0002",505,41,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1434,1,"Censored at the last contact date","ADVERSE EVENT"
"1518","PSIVISSIG0002",506,27,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",483,1,"Censored at the last contact date","ADVERSE EVENT"
"1519","PSIVISSIG0002",507,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",197,1,"Censored at the last contact date","ADVERSE EVENT"
"1520","PSIVISSIG0002",508,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",567,1,"Censored at the last contact date","DEATH"
"1521","PSIVISSIG0002",509,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",113,1,"Censored at the last contact date","DEATH"
"1522","PSIVISSIG0002",510,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",817,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1523","PSIVISSIG0002",511,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",113,1,"Censored at the last contact date","ADVERSE EVENT"
"1524","PSIVISSIG0002",512,45,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1654,1,"Censored at the last contact date","ADVERSE EVENT"
"1525","PSIVISSIG0002",513,32,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",713,1,"Censored at the last contact date","ADVERSE EVENT"
"1526","PSIVISSIG0002",514,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1527","PSIVISSIG0002",515,58,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1528","PSIVISSIG0002",516,37,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",329,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1529","PSIVISSIG0002",517,38,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1552,1,"Censored at the last contact date","DEATH"
"1530","PSIVISSIG0002",518,35,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1245,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1531","PSIVISSIG0002",519,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1517,1,"Censored at the last contact date","ADVERSE EVENT"
"1532","PSIVISSIG0002",520,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1533","PSIVISSIG0002",521,47,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1624,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1534","PSIVISSIG0002",522,31,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",125,1,"Censored at the last contact date","ADVERSE EVENT"
"1535","PSIVISSIG0002",523,44,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",275,1,"Censored at the last contact date","ADVERSE EVENT"
"1536","PSIVISSIG0002",524,38,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",354,1,"Censored at the last contact date","ADVERSE EVENT"
"1537","PSIVISSIG0002",525,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1538","PSIVISSIG0002",526,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1539","PSIVISSIG0002",527,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",669,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1540","PSIVISSIG0002",528,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",453,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1541","PSIVISSIG0002",529,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1542","PSIVISSIG0002",530,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",143,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1543","PSIVISSIG0002",531,57,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",459,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1544","PSIVISSIG0002",532,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1369,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1545","PSIVISSIG0002",533,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1308,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1546","PSIVISSIG0002",534,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1518,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1547","PSIVISSIG0002",535,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",83,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1548","PSIVISSIG0002",536,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1528,1,"Censored at the last contact date","ADVERSE EVENT"
"1549","PSIVISSIG0002",537,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1550","PSIVISSIG0002",538,35,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1551","PSIVISSIG0002",539,52,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",568,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1552","PSIVISSIG0002",540,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",299,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1553","PSIVISSIG0002",541,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1635,1,"Censored at the last contact date","ADVERSE EVENT"
"1554","PSIVISSIG0002",542,38,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",264,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1555","PSIVISSIG0002",543,37,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",88,1,"Censored at the last contact date","ADVERSE EVENT"
"1556","PSIVISSIG0002",544,60,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",235,1,"Censored at the last contact date","DEATH"
"1557","PSIVISSIG0002",545,49,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",886,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1558","PSIVISSIG0002",546,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1559","PSIVISSIG0002",547,54,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",147,1,"Censored at the last contact date","ADVERSE EVENT"
"1560","PSIVISSIG0002",548,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",485,1,"Censored at the last contact date","ADVERSE EVENT"
"1561","PSIVISSIG0002",549,49,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1562","PSIVISSIG0002",550,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1563","PSIVISSIG0002",551,31,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",28,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1564","PSIVISSIG0002",552,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1637,1,"Censored at the last contact date","ADVERSE EVENT"
"1565","PSIVISSIG0002",553,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",644,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1566","PSIVISSIG0002",554,45,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",232,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1567","PSIVISSIG0002",555,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",491,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1568","PSIVISSIG0002",556,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1162,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1569","PSIVISSIG0002",557,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1210,1,"Censored at the last contact date","ADVERSE EVENT"
"1570","PSIVISSIG0002",558,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",292,1,"Censored at the last contact date","ADVERSE EVENT"
"1571","PSIVISSIG0002",559,58,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",570,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1572","PSIVISSIG0002",560,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",67,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1573","PSIVISSIG0002",561,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1543,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1574","PSIVISSIG0002",562,27,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",668,1,"Censored at the last contact date","ADVERSE EVENT"
"1575","PSIVISSIG0002",563,47,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1502,1,"Censored at the last contact date","ADVERSE EVENT"
"1576","PSIVISSIG0002",564,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",93,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1577","PSIVISSIG0002",565,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1052,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1578","PSIVISSIG0002",566,50,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1579","PSIVISSIG0002",567,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",400,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1580","PSIVISSIG0002",568,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",688,1,"Censored at the last contact date","ADVERSE EVENT"
"1581","PSIVISSIG0002",569,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",61,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1582","PSIVISSIG0002",570,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1770,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1583","PSIVISSIG0002",571,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",162,1,"Censored at the last contact date","DEATH"
"1584","PSIVISSIG0002",572,44,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",225,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1585","PSIVISSIG0002",573,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",207,1,"Censored at the last contact date","ADVERSE EVENT"
"1586","PSIVISSIG0002",574,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",412,1,"Censored at the last contact date","DEATH"
"1587","PSIVISSIG0002",575,49,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",332,1,"Censored at the last contact date","ADVERSE EVENT"
"1588","PSIVISSIG0002",576,29,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1401,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1589","PSIVISSIG0002",577,53,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",214,1,"Censored at the last contact date","ADVERSE EVENT"
"1590","PSIVISSIG0002",578,32,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",429,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1591","PSIVISSIG0002",579,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",669,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1592","PSIVISSIG0002",580,36,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",657,1,"Censored at the last contact date","ADVERSE EVENT"
"1593","PSIVISSIG0002",581,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1594","PSIVISSIG0002",582,60,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",77,1,"Censored at the last contact date","ADVERSE EVENT"
"1595","PSIVISSIG0002",583,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",280,1,"Censored at the last contact date","ADVERSE EVENT"
"1596","PSIVISSIG0002",584,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1278,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1597","PSIVISSIG0002",585,58,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",406,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1598","PSIVISSIG0002",586,33,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1599","PSIVISSIG0002",587,50,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1330,1,"Censored at the last contact date","ADVERSE EVENT"
"1600","PSIVISSIG0002",588,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",20,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1601","PSIVISSIG0002",589,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1295,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1602","PSIVISSIG0002",590,60,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",578,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1603","PSIVISSIG0002",591,47,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",258,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1604","PSIVISSIG0002",592,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",340,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1605","PSIVISSIG0002",593,39,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",25,1,"Censored at the last contact date","ADVERSE EVENT"
"1606","PSIVISSIG0002",594,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",240,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1607","PSIVISSIG0002",595,43,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",772,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1608","PSIVISSIG0002",596,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1362,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1609","PSIVISSIG0002",597,31,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1632,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1610","PSIVISSIG0002",598,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",435,1,"Censored at the last contact date","ADVERSE EVENT"
"1611","PSIVISSIG0002",599,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1612","PSIVISSIG0002",600,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",20,1,"Censored at the last contact date","ADVERSE EVENT"
"1613","PSIVISSIG0002",601,39,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",49,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1614","PSIVISSIG0002",602,21,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",313,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1615","PSIVISSIG0002",603,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1616","PSIVISSIG0002",604,34,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1617","PSIVISSIG0002",605,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",117,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1618","PSIVISSIG0002",606,49,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",431,1,"Censored at the last contact date","ADVERSE EVENT"
"1619","PSIVISSIG0002",607,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",686,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1620","PSIVISSIG0002",608,56,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",609,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1621","PSIVISSIG0002",609,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1666,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1622","PSIVISSIG0002",610,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",623,1,"Censored at the last contact date","ADVERSE EVENT"
"1623","PSIVISSIG0002",611,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",244,1,"Censored at the last contact date","ADVERSE EVENT"
"1624","PSIVISSIG0002",612,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1625","PSIVISSIG0002",613,43,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",242,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1626","PSIVISSIG0002",614,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",400,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1627","PSIVISSIG0002",615,35,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",154,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1628","PSIVISSIG0002",616,61,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",396,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1629","PSIVISSIG0002",617,41,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1630","PSIVISSIG0002",618,38,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",89,1,"Censored at the last contact date","ADVERSE EVENT"
"1631","PSIVISSIG0002",619,28,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",268,1,"Censored at the last contact date","ADVERSE EVENT"
"1632","PSIVISSIG0002",620,38,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",69,1,"Censored at the last contact date","ADVERSE EVENT"
"1633","PSIVISSIG0002",621,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1144,1,"Censored at the last contact date","ADVERSE EVENT"
"1634","PSIVISSIG0002",622,24,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",629,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1635","PSIVISSIG0002",623,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",556,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1636","PSIVISSIG0002",624,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",233,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1637","PSIVISSIG0002",625,51,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1638","PSIVISSIG0002",626,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1714,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1639","PSIVISSIG0002",627,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1640","PSIVISSIG0002",628,34,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1641","PSIVISSIG0002",629,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",63,1,"Censored at the last contact date","ADVERSE EVENT"
"1642","PSIVISSIG0002",630,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1160,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1643","PSIVISSIG0002",631,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",785,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1644","PSIVISSIG0002",632,56,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",852,1,"Censored at the last contact date","ADVERSE EVENT"
"1645","PSIVISSIG0002",633,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1646","PSIVISSIG0002",634,56,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",738,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1647","PSIVISSIG0002",635,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",440,1,"Censored at the last contact date","ADVERSE EVENT"
"1648","PSIVISSIG0002",636,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1674,1,"Censored at the last contact date","ADVERSE EVENT"
"1649","PSIVISSIG0002",637,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",573,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1650","PSIVISSIG0002",638,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1651","PSIVISSIG0002",639,67,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",416,1,"Censored at the last contact date","ADVERSE EVENT"
"1652","PSIVISSIG0002",640,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",131,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1653","PSIVISSIG0002",641,50,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1654","PSIVISSIG0002",642,38,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",55,1,"Censored at the last contact date","ADVERSE EVENT"
"1655","PSIVISSIG0002",643,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1141,1,"Censored at the last contact date","ADVERSE EVENT"
"1656","PSIVISSIG0002",644,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1657","PSIVISSIG0002",645,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1658","PSIVISSIG0002",646,36,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1659","PSIVISSIG0002",647,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1707,1,"Censored at the last contact date","DEATH"
"1660","PSIVISSIG0002",648,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",323,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1661","PSIVISSIG0002",649,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",439,1,"Censored at the last contact date","ADVERSE EVENT"
"1662","PSIVISSIG0002",650,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",40,1,"Censored at the last contact date","ADVERSE EVENT"
"1663","PSIVISSIG0002",651,64,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",818,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1664","PSIVISSIG0002",652,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1525,1,"Censored at the last contact date","ADVERSE EVENT"
"1665","PSIVISSIG0002",653,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1171,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1666","PSIVISSIG0002",654,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1667","PSIVISSIG0002",655,43,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",704,1,"Censored at the last contact date","ADVERSE EVENT"
"1668","PSIVISSIG0002",656,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",868,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1669","PSIVISSIG0002",657,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",832,1,"Censored at the last contact date","ADVERSE EVENT"
"1670","PSIVISSIG0002",658,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",189,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1671","PSIVISSIG0002",659,33,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",423,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1672","PSIVISSIG0002",660,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",175,1,"Censored at the last contact date","ADVERSE EVENT"
"1673","PSIVISSIG0002",661,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",288,1,"Censored at the last contact date","ADVERSE EVENT"
"1674","PSIVISSIG0002",662,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1675","PSIVISSIG0002",663,31,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",150,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1676","PSIVISSIG0002",664,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",220,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1677","PSIVISSIG0002",665,27,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1678","PSIVISSIG0002",666,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",716,1,"Censored at the last contact date","ADVERSE EVENT"
"1679","PSIVISSIG0002",667,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",49,1,"Censored at the last contact date","ADVERSE EVENT"
"1680","PSIVISSIG0002",668,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",718,1,"Censored at the last contact date","ADVERSE EVENT"
"1681","PSIVISSIG0002",669,32,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",466,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1682","PSIVISSIG0002",670,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1498,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1683","PSIVISSIG0002",671,59,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",266,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1684","PSIVISSIG0002",672,38,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1645,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1685","PSIVISSIG0002",673,47,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1387,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1686","PSIVISSIG0002",674,51,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",586,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1687","PSIVISSIG0002",675,40,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",671,1,"Censored at the last contact date","DEATH"
"1688","PSIVISSIG0002",676,56,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",94,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1689","PSIVISSIG0002",677,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",901,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1690","PSIVISSIG0002",678,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",322,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1691","PSIVISSIG0002",679,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",998,1,"Censored at the last contact date","ADVERSE EVENT"
"1692","PSIVISSIG0002",680,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",278,1,"Censored at the last contact date","ADVERSE EVENT"
"1693","PSIVISSIG0002",681,48,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",982,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1694","PSIVISSIG0002",682,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",112,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1695","PSIVISSIG0002",683,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1696","PSIVISSIG0002",684,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",708,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1697","PSIVISSIG0002",685,40,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1698","PSIVISSIG0002",686,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",673,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1699","PSIVISSIG0002",687,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1200,1,"Censored at the last contact date","ADVERSE EVENT"
"1700","PSIVISSIG0002",688,60,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",456,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1701","PSIVISSIG0002",689,54,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",37,1,"Censored at the last contact date","ADVERSE EVENT"
"1702","PSIVISSIG0002",690,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1703","PSIVISSIG0002",691,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",957,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1704","PSIVISSIG0002",692,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1494,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1705","PSIVISSIG0002",693,47,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",16,1,"Censored at the last contact date","ADVERSE EVENT"
"1706","PSIVISSIG0002",694,29,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1707","PSIVISSIG0002",695,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",810,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1708","PSIVISSIG0002",696,35,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",501,1,"Censored at the last contact date","DEATH"
"1709","PSIVISSIG0002",697,49,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",278,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1710","PSIVISSIG0002",698,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",10,1,"Censored at the last contact date","ADVERSE EVENT"
"1711","PSIVISSIG0002",699,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",591,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1712","PSIVISSIG0002",700,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",67,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1713","PSIVISSIG0002",701,36,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",935,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1714","PSIVISSIG0002",702,55,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",874,1,"Censored at the last contact date","ADVERSE EVENT"
"1715","PSIVISSIG0002",703,34,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1096,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1716","PSIVISSIG0002",704,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",416,1,"Censored at the last contact date","ADVERSE EVENT"
"1717","PSIVISSIG0002",705,30,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",903,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1718","PSIVISSIG0002",706,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1709,1,"Censored at the last contact date","ADVERSE EVENT"
"1719","PSIVISSIG0002",707,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1720","PSIVISSIG0002",708,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1273,1,"Censored at the last contact date","ADVERSE EVENT"
"1721","PSIVISSIG0002",709,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",658,1,"Censored at the last contact date","ADVERSE EVENT"
"1722","PSIVISSIG0002",710,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",136,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1723","PSIVISSIG0002",711,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",179,1,"Censored at the last contact date","ADVERSE EVENT"
"1724","PSIVISSIG0002",712,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1725","PSIVISSIG0002",713,48,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",49,1,"Censored at the last contact date","ADVERSE EVENT"
"1726","PSIVISSIG0002",714,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",415,1,"Censored at the last contact date","ADVERSE EVENT"
"1727","PSIVISSIG0002",715,42,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",438,1,"Censored at the last contact date","ADVERSE EVENT"
"1728","PSIVISSIG0002",716,57,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",400,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1729","PSIVISSIG0002",717,37,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",856,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1730","PSIVISSIG0002",718,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1731","PSIVISSIG0002",719,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",477,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1732","PSIVISSIG0002",720,41,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1733","PSIVISSIG0002",721,26,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1214,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1734","PSIVISSIG0002",722,41,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1142,1,"Censored at the last contact date","ADVERSE EVENT"
"1735","PSIVISSIG0002",723,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",430,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1736","PSIVISSIG0002",724,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",267,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1737","PSIVISSIG0002",725,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",295,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1738","PSIVISSIG0002",726,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",429,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1739","PSIVISSIG0002",727,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",134,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1740","PSIVISSIG0002",728,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1741","PSIVISSIG0002",729,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1343,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1742","PSIVISSIG0002",730,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1305,1,"Censored at the last contact date","ADVERSE EVENT"
"1743","PSIVISSIG0002",731,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",67,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1744","PSIVISSIG0002",732,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",24,1,"Censored at the last contact date","ADVERSE EVENT"
"1745","PSIVISSIG0002",733,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1746","PSIVISSIG0002",734,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1747","PSIVISSIG0002",735,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1748","PSIVISSIG0002",736,28,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1749","PSIVISSIG0002",737,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1197,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1750","PSIVISSIG0002",738,34,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1751","PSIVISSIG0002",739,43,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",2,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1752","PSIVISSIG0002",740,37,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1105,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1753","PSIVISSIG0002",741,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1754","PSIVISSIG0002",742,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1246,1,"Censored at the last contact date","ADVERSE EVENT"
"1755","PSIVISSIG0002",743,31,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",212,1,"Censored at the last contact date","ADVERSE EVENT"
"1756","PSIVISSIG0002",744,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1757","PSIVISSIG0002",745,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",598,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1758","PSIVISSIG0002",746,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1454,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1759","PSIVISSIG0002",747,26,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1760","PSIVISSIG0002",748,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",347,1,"Censored at the last contact date","ADVERSE EVENT"
"1761","PSIVISSIG0002",749,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",35,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1762","PSIVISSIG0002",750,51,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",42,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1763","PSIVISSIG0002",751,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",85,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1764","PSIVISSIG0002",752,42,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",173,1,"Censored at the last contact date","ADVERSE EVENT"
"1765","PSIVISSIG0002",753,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1408,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1766","PSIVISSIG0002",754,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",634,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1767","PSIVISSIG0002",755,55,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1768","PSIVISSIG0002",756,57,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1769","PSIVISSIG0002",757,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",391,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1770","PSIVISSIG0002",758,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1771","PSIVISSIG0002",759,29,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1772","PSIVISSIG0002",760,65,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",412,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1773","PSIVISSIG0002",761,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",146,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1774","PSIVISSIG0002",762,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1143,1,"Censored at the last contact date","ADVERSE EVENT"
"1775","PSIVISSIG0002",763,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",214,1,"Censored at the last contact date","DEATH"
"1776","PSIVISSIG0002",764,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1777","PSIVISSIG0002",765,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1269,1,"Censored at the last contact date","ADVERSE EVENT"
"1778","PSIVISSIG0002",766,25,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",28,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1779","PSIVISSIG0002",767,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1780","PSIVISSIG0002",768,61,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1616,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1781","PSIVISSIG0002",769,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",555,1,"Censored at the last contact date","ADVERSE EVENT"
"1782","PSIVISSIG0002",770,56,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1783","PSIVISSIG0002",771,56,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1784","PSIVISSIG0002",772,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",366,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1785","PSIVISSIG0002",773,45,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",12,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1786","PSIVISSIG0002",774,38,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1551,1,"Censored at the last contact date","ADVERSE EVENT"
"1787","PSIVISSIG0002",775,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",109,1,"Censored at the last contact date","ADVERSE EVENT"
"1788","PSIVISSIG0002",776,31,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",900,1,"Censored at the last contact date","ADVERSE EVENT"
"1789","PSIVISSIG0002",777,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",238,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1790","PSIVISSIG0002",778,31,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",48,1,"Censored at the last contact date","ADVERSE EVENT"
"1791","PSIVISSIG0002",779,38,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",330,1,"Censored at the last contact date","ADVERSE EVENT"
"1792","PSIVISSIG0002",780,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",753,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1793","PSIVISSIG0002",781,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",582,1,"Censored at the last contact date","ADVERSE EVENT"
"1794","PSIVISSIG0002",782,41,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1795","PSIVISSIG0002",783,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1270,1,"Censored at the last contact date","ADVERSE EVENT"
"1796","PSIVISSIG0002",784,62,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",132,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1797","PSIVISSIG0002",785,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",459,1,"Censored at the last contact date","ADVERSE EVENT"
"1798","PSIVISSIG0002",786,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1799","PSIVISSIG0002",787,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",567,1,"Censored at the last contact date","ADVERSE EVENT"
"1800","PSIVISSIG0002",788,49,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",104,1,"Censored at the last contact date","ADVERSE EVENT"
"1801","PSIVISSIG0002",789,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",108,1,"Censored at the last contact date","ADVERSE EVENT"
"1802","PSIVISSIG0002",790,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",443,1,"Censored at the last contact date","ADVERSE EVENT"
"1803","PSIVISSIG0002",791,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1804","PSIVISSIG0002",792,41,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",557,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1805","PSIVISSIG0002",793,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1235,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1806","PSIVISSIG0002",794,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1414,1,"Censored at the last contact date","ADVERSE EVENT"
"1807","PSIVISSIG0002",795,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",663,1,"Censored at the last contact date","DEATH"
"1808","PSIVISSIG0002",796,57,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1658,1,"Censored at the last contact date","ADVERSE EVENT"
"1809","PSIVISSIG0002",797,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",620,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1810","PSIVISSIG0002",798,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1730,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1811","PSIVISSIG0002",799,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",93,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1812","PSIVISSIG0002",800,53,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1813","PSIVISSIG0002",801,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",54,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1814","PSIVISSIG0002",802,60,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",805,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1815","PSIVISSIG0002",803,50,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",99,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1816","PSIVISSIG0002",804,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1817","PSIVISSIG0002",805,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",476,1,"Censored at the last contact date","ADVERSE EVENT"
"1818","PSIVISSIG0002",806,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",340,1,"Censored at the last contact date","ADVERSE EVENT"
"1819","PSIVISSIG0002",807,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1820","PSIVISSIG0002",808,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1187,1,"Censored at the last contact date","ADVERSE EVENT"
"1821","PSIVISSIG0002",809,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",218,1,"Censored at the last contact date","ADVERSE EVENT"
"1822","PSIVISSIG0002",810,31,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",899,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1823","PSIVISSIG0002",811,33,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1412,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1824","PSIVISSIG0002",812,52,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",530,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1825","PSIVISSIG0002",813,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",58,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1826","PSIVISSIG0002",814,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1827","PSIVISSIG0002",815,52,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",108,1,"Censored at the last contact date","DEATH"
"1828","PSIVISSIG0002",816,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",320,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1829","PSIVISSIG0002",817,63,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",277,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1830","PSIVISSIG0002",818,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",727,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1831","PSIVISSIG0002",819,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1832","PSIVISSIG0002",820,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",510,1,"Censored at the last contact date","ADVERSE EVENT"
"1833","PSIVISSIG0002",821,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1834","PSIVISSIG0002",822,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",151,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1835","PSIVISSIG0002",823,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",531,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1836","PSIVISSIG0002",824,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1221,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1837","PSIVISSIG0002",825,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",464,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1838","PSIVISSIG0002",826,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",442,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1839","PSIVISSIG0002",827,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1231,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1840","PSIVISSIG0002",828,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",56,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1841","PSIVISSIG0002",829,35,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1842","PSIVISSIG0002",830,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1158,1,"Censored at the last contact date","DEATH"
"1843","PSIVISSIG0002",831,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",174,1,"Censored at the last contact date","ADVERSE EVENT"
"1844","PSIVISSIG0002",832,48,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",251,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1845","PSIVISSIG0002",833,29,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",335,1,"Censored at the last contact date","ADVERSE EVENT"
"1846","PSIVISSIG0002",834,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1728,1,"Censored at the last contact date","ADVERSE EVENT"
"1847","PSIVISSIG0002",835,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",450,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1848","PSIVISSIG0002",836,56,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",16,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1849","PSIVISSIG0002",837,38,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",638,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1850","PSIVISSIG0002",838,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1354,1,"Censored at the last contact date","ADVERSE EVENT"
"1851","PSIVISSIG0002",839,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",358,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1852","PSIVISSIG0002",840,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",266,1,"Censored at the last contact date","ADVERSE EVENT"
"1853","PSIVISSIG0002",841,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",509,1,"Censored at the last contact date","DEATH"
"1854","PSIVISSIG0002",842,57,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",450,1,"Censored at the last contact date","DEATH"
"1855","PSIVISSIG0002",843,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",258,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1856","PSIVISSIG0002",844,29,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",865,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1857","PSIVISSIG0002",845,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1362,1,"Censored at the last contact date","ADVERSE EVENT"
"1858","PSIVISSIG0002",846,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",703,1,"Censored at the last contact date","ADVERSE EVENT"
"1859","PSIVISSIG0002",847,34,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",515,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1860","PSIVISSIG0002",848,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",89,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1861","PSIVISSIG0002",849,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",267,1,"Censored at the last contact date","ADVERSE EVENT"
"1862","PSIVISSIG0002",850,45,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",154,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1863","PSIVISSIG0002",851,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",144,1,"Censored at the last contact date","ADVERSE EVENT"
"1864","PSIVISSIG0002",852,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",587,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1865","PSIVISSIG0002",853,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",405,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1866","PSIVISSIG0002",854,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",896,1,"Censored at the last contact date","ADVERSE EVENT"
"1867","PSIVISSIG0002",855,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1070,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1868","PSIVISSIG0002",856,64,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1869","PSIVISSIG0002",857,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",370,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1870","PSIVISSIG0002",858,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1642,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1871","PSIVISSIG0002",859,44,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",61,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1872","PSIVISSIG0002",860,59,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",644,1,"Censored at the last contact date","DEATH"
"1873","PSIVISSIG0002",861,26,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1874","PSIVISSIG0002",862,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",361,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1875","PSIVISSIG0002",863,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1061,1,"Censored at the last contact date","ADVERSE EVENT"
"1876","PSIVISSIG0002",864,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",188,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1877","PSIVISSIG0002",865,27,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",478,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1878","PSIVISSIG0002",866,42,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",388,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1879","PSIVISSIG0002",867,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",952,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1880","PSIVISSIG0002",868,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",585,1,"Censored at the last contact date","ADVERSE EVENT"
"1881","PSIVISSIG0002",869,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",348,1,"Censored at the last contact date","DEATH"
"1882","PSIVISSIG0002",870,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1883","PSIVISSIG0002",871,29,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",235,1,"Censored at the last contact date","ADVERSE EVENT"
"1884","PSIVISSIG0002",872,33,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",619,1,"Censored at the last contact date","ADVERSE EVENT"
"1885","PSIVISSIG0002",873,61,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1886","PSIVISSIG0002",874,58,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",273,1,"Censored at the last contact date","ADVERSE EVENT"
"1887","PSIVISSIG0002",875,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",624,1,"Censored at the last contact date","ADVERSE EVENT"
"1888","PSIVISSIG0002",876,29,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1889","PSIVISSIG0002",877,42,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",62,1,"Censored at the last contact date","ADVERSE EVENT"
"1890","PSIVISSIG0002",878,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",660,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1891","PSIVISSIG0002",879,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1097,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1892","PSIVISSIG0002",880,43,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1893","PSIVISSIG0002",881,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",82,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1894","PSIVISSIG0002",882,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1389,1,"Censored at the last contact date","ADVERSE EVENT"
"1895","PSIVISSIG0002",883,62,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",343,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1896","PSIVISSIG0002",884,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1419,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1897","PSIVISSIG0002",885,47,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",38,1,"Censored at the last contact date","DEATH"
"1898","PSIVISSIG0002",886,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",51,1,"Censored at the last contact date","ADVERSE EVENT"
"1899","PSIVISSIG0002",887,45,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",927,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1900","PSIVISSIG0002",888,53,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",796,1,"Censored at the last contact date","DEATH"
"1901","PSIVISSIG0002",889,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1562,1,"Censored at the last contact date","ADVERSE EVENT"
"1902","PSIVISSIG0002",890,41,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",928,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1903","PSIVISSIG0002",891,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1611,1,"Censored at the last contact date","DEATH"
"1904","PSIVISSIG0002",892,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1067,1,"Censored at the last contact date","DEATH"
"1905","PSIVISSIG0002",893,42,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1906","PSIVISSIG0002",894,57,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",383,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1907","PSIVISSIG0002",895,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",788,1,"Censored at the last contact date","ADVERSE EVENT"
"1908","PSIVISSIG0002",896,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1067,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1909","PSIVISSIG0002",897,31,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",969,1,"Censored at the last contact date","DEATH"
"1910","PSIVISSIG0002",898,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1911","PSIVISSIG0002",899,61,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",50,1,"Censored at the last contact date","ADVERSE EVENT"
"1912","PSIVISSIG0002",900,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1913","PSIVISSIG0002",901,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1914","PSIVISSIG0002",902,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",459,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1915","PSIVISSIG0002",903,37,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",568,1,"Censored at the last contact date","ADVERSE EVENT"
"1916","PSIVISSIG0002",904,47,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",566,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1917","PSIVISSIG0002",905,51,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1137,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1918","PSIVISSIG0002",906,43,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1586,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1919","PSIVISSIG0002",907,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",535,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1920","PSIVISSIG0002",908,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",187,1,"Censored at the last contact date","ADVERSE EVENT"
"1921","PSIVISSIG0002",909,34,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",710,1,"Censored at the last contact date","ADVERSE EVENT"
"1922","PSIVISSIG0002",910,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",864,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1923","PSIVISSIG0002",911,60,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",314,1,"Censored at the last contact date","ADVERSE EVENT"
"1924","PSIVISSIG0002",912,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1574,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1925","PSIVISSIG0002",913,54,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1926","PSIVISSIG0002",914,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",145,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1927","PSIVISSIG0002",915,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1421,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1928","PSIVISSIG0002",916,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",369,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1929","PSIVISSIG0002",917,60,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",232,1,"Censored at the last contact date","ADVERSE EVENT"
"1930","PSIVISSIG0002",918,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",117,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1931","PSIVISSIG0002",919,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",255,1,"Censored at the last contact date","ADVERSE EVENT"
"1932","PSIVISSIG0002",920,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",598,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1933","PSIVISSIG0002",921,40,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",894,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1934","PSIVISSIG0002",922,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",201,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1935","PSIVISSIG0002",923,48,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1936","PSIVISSIG0002",924,43,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1152,1,"Censored at the last contact date","ADVERSE EVENT"
"1937","PSIVISSIG0002",925,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",692,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1938","PSIVISSIG0002",926,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1939","PSIVISSIG0002",927,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",690,1,"Censored at the last contact date","ADVERSE EVENT"
"1940","PSIVISSIG0002",928,37,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1166,1,"Censored at the last contact date","ADVERSE EVENT"
"1941","PSIVISSIG0002",929,60,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",433,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1942","PSIVISSIG0002",930,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",647,1,"Censored at the last contact date","DEATH"
"1943","PSIVISSIG0002",931,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1027,1,"Censored at the last contact date","ADVERSE EVENT"
"1944","PSIVISSIG0002",932,41,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",348,1,"Censored at the last contact date","ADVERSE EVENT"
"1945","PSIVISSIG0002",933,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",935,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1946","PSIVISSIG0002",934,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",292,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1947","PSIVISSIG0002",935,34,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",872,1,"Censored at the last contact date","ADVERSE EVENT"
"1948","PSIVISSIG0002",936,50,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1058,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1949","PSIVISSIG0002",937,51,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1486,1,"Censored at the last contact date","ADVERSE EVENT"
"1950","PSIVISSIG0002",938,60,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",965,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1951","PSIVISSIG0002",939,28,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1349,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1952","PSIVISSIG0002",940,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1244,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1953","PSIVISSIG0002",941,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1954","PSIVISSIG0002",942,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1115,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1955","PSIVISSIG0002",943,57,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1956","PSIVISSIG0002",944,41,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",186,1,"Censored at the last contact date","ADVERSE EVENT"
"1957","PSIVISSIG0002",945,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",441,1,"Censored at the last contact date","DEATH"
"1958","PSIVISSIG0002",946,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1959","PSIVISSIG0002",947,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1679,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1960","PSIVISSIG0002",948,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",93,1,"Censored at the last contact date","ADVERSE EVENT"
"1961","PSIVISSIG0002",949,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1534,1,"Censored at the last contact date","ADVERSE EVENT"
"1962","PSIVISSIG0002",950,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1963","PSIVISSIG0002",951,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",325,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1964","PSIVISSIG0002",952,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",758,1,"Censored at the last contact date","ADVERSE EVENT"
"1965","PSIVISSIG0002",953,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1966","PSIVISSIG0002",954,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1967","PSIVISSIG0002",955,56,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",22,1,"Censored at the last contact date","ADVERSE EVENT"
"1968","PSIVISSIG0002",956,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1036,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1969","PSIVISSIG0002",957,45,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1406,1,"Censored at the last contact date","ADVERSE EVENT"
"1970","PSIVISSIG0002",958,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",395,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1971","PSIVISSIG0002",959,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1541,1,"Censored at the last contact date","ADVERSE EVENT"
"1972","PSIVISSIG0002",960,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1973","PSIVISSIG0002",961,30,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",553,1,"Censored at the last contact date","ADVERSE EVENT"
"1974","PSIVISSIG0002",962,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1145,1,"Censored at the last contact date","ADVERSE EVENT"
"1975","PSIVISSIG0002",963,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",995,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1976","PSIVISSIG0002",964,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1977","PSIVISSIG0002",965,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",301,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1978","PSIVISSIG0002",966,60,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",268,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1979","PSIVISSIG0002",967,56,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",459,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1980","PSIVISSIG0002",968,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1064,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1981","PSIVISSIG0002",969,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",377,1,"Censored at the last contact date","ADVERSE EVENT"
"1982","PSIVISSIG0002",970,41,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",76,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1983","PSIVISSIG0002",971,48,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",134,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1984","PSIVISSIG0002",972,42,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1138,1,"Censored at the last contact date","ADVERSE EVENT"
"1985","PSIVISSIG0002",973,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",535,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1986","PSIVISSIG0002",974,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1310,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1987","PSIVISSIG0002",975,56,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",425,1,"Censored at the last contact date","ADVERSE EVENT"
"1988","PSIVISSIG0002",976,39,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1989","PSIVISSIG0002",977,31,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",108,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1990","PSIVISSIG0002",978,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",225,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1991","PSIVISSIG0002",979,53,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",88,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1992","PSIVISSIG0002",980,49,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",944,1,"Censored at the last contact date","ADVERSE EVENT"
"1993","PSIVISSIG0002",981,54,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",697,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1994","PSIVISSIG0002",982,52,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",437,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1995","PSIVISSIG0002",983,46,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1996","PSIVISSIG0002",984,36,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"1997","PSIVISSIG0002",985,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",904,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1998","PSIVISSIG0002",986,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",985,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"1999","PSIVISSIG0002",987,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",422,1,"Censored at the last contact date","ADVERSE EVENT"
"2000","PSIVISSIG0002",988,44,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",255,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2001","PSIVISSIG0002",989,49,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"2002","PSIVISSIG0002",990,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",827,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2003","PSIVISSIG0002",991,52,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",518,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2004","PSIVISSIG0002",992,55,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1076,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2005","PSIVISSIG0002",993,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",42,1,"Censored at the last contact date","ADVERSE EVENT"
"2006","PSIVISSIG0002",994,41,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"2007","PSIVISSIG0002",995,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",113,1,"Censored at the last contact date","ADVERSE EVENT"
"2008","PSIVISSIG0002",996,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1056,1,"Censored at the last contact date","ADVERSE EVENT"
"2009","PSIVISSIG0002",997,32,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",991,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2010","PSIVISSIG0002",998,43,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",12,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2011","PSIVISSIG0002",999,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",389,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2012","PSIVISSIG0002",1000,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1490,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2013","PSIVISSIG0002",1001,51,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",275,1,"Censored at the last contact date","ADVERSE EVENT"
"2014","PSIVISSIG0002",1002,32,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",537,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2015","PSIVISSIG0002",1003,55,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",231,1,"Censored at the last contact date","ADVERSE EVENT"
"2016","PSIVISSIG0002",1004,41,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",520,1,"Censored at the last contact date","ADVERSE EVENT"
"2017","PSIVISSIG0002",1005,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",160,1,"Censored at the last contact date","ADVERSE EVENT"
"2018","PSIVISSIG0002",1006,51,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"2019","PSIVISSIG0002",1007,44,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",303,1,"Censored at the last contact date","ADVERSE EVENT"
"2020","PSIVISSIG0002",1008,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1,1,"Censored at the last contact date","ADVERSE EVENT"
"2021","PSIVISSIG0002",1009,52,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",985,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2022","PSIVISSIG0002",1010,36,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1085,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2023","PSIVISSIG0002",1011,23,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1175,1,"Censored at the last contact date","ADVERSE EVENT"
"2024","PSIVISSIG0002",1012,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",362,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2025","PSIVISSIG0002",1013,39,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",483,1,"Censored at the last contact date","ADVERSE EVENT"
"2026","PSIVISSIG0002",1014,29,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",235,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2027","PSIVISSIG0002",1015,37,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",468,1,"Censored at the last contact date","ADVERSE EVENT"
"2028","PSIVISSIG0002",1016,50,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1521,1,"Censored at the last contact date","ADVERSE EVENT"
"2029","PSIVISSIG0002",1017,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"2030","PSIVISSIG0002",1018,31,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1058,1,"Censored at the last contact date","ADVERSE EVENT"
"2031","PSIVISSIG0002",1019,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",274,1,"Censored at the last contact date","DEATH"
"2032","PSIVISSIG0002",1020,49,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",44,1,"Censored at the last contact date","ADVERSE EVENT"
"2033","PSIVISSIG0002",1021,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"2034","PSIVISSIG0002",1022,43,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"2035","PSIVISSIG0002",1023,57,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",925,1,"Censored at the last contact date","ADVERSE EVENT"
"2036","PSIVISSIG0002",1024,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",573,1,"Censored at the last contact date","ADVERSE EVENT"
"2037","PSIVISSIG0002",1025,49,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",435,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2038","PSIVISSIG0002",1026,51,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",495,1,"Censored at the last contact date","ADVERSE EVENT"
"2039","PSIVISSIG0002",1027,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",472,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2040","PSIVISSIG0002",1028,24,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",692,1,"Censored at the last contact date","ADVERSE EVENT"
"2041","PSIVISSIG0002",1029,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",392,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2042","PSIVISSIG0002",1030,44,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1338,1,"Censored at the last contact date","ADVERSE EVENT"
"2043","PSIVISSIG0002",1031,31,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1530,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2044","PSIVISSIG0002",1032,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",453,1,"Censored at the last contact date","ADVERSE EVENT"
"2045","PSIVISSIG0002",1033,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1732,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2046","PSIVISSIG0002",1034,30,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",672,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2047","PSIVISSIG0002",1035,32,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",252,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2048","PSIVISSIG0002",1036,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",235,1,"Censored at the last contact date","ADVERSE EVENT"
"2049","PSIVISSIG0002",1037,35,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",795,1,"Censored at the last contact date","DEATH"
"2050","PSIVISSIG0002",1038,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1660,1,"Censored at the last contact date","ADVERSE EVENT"
"2051","PSIVISSIG0002",1039,53,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1217,1,"Censored at the last contact date","ADVERSE EVENT"
"2052","PSIVISSIG0002",1040,34,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",383,1,"Censored at the last contact date","ADVERSE EVENT"
"2053","PSIVISSIG0002",1041,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"2054","PSIVISSIG0002",1042,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",350,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2055","PSIVISSIG0002",1043,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",16,1,"Censored at the last contact date","DEATH"
"2056","PSIVISSIG0002",1044,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",391,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2057","PSIVISSIG0002",1045,42,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",103,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2058","PSIVISSIG0002",1046,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",63,1,"Censored at the last contact date","ADVERSE EVENT"
"2059","PSIVISSIG0002",1047,39,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"2060","PSIVISSIG0002",1048,39,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",369,1,"Censored at the last contact date","ADVERSE EVENT"
"2061","PSIVISSIG0002",1049,30,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",822,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2062","PSIVISSIG0002",1050,57,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1047,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2063","PSIVISSIG0002",1051,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",156,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2064","PSIVISSIG0002",1052,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",587,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2065","PSIVISSIG0002",1053,49,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",105,1,"Censored at the last contact date","ADVERSE EVENT"
"2066","PSIVISSIG0002",1054,46,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1328,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2067","PSIVISSIG0002",1055,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",864,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2068","PSIVISSIG0002",1056,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"2069","PSIVISSIG0002",1057,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"2070","PSIVISSIG0002",1058,38,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
"2071","PSIVISSIG0002",1059,38,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",722,1,"Censored at the last contact date","ADVERSE EVENT"
"2072","PSIVISSIG0002",1060,53,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",333,1,"Censored at the last contact date","ADVERSE EVENT"
"2073","PSIVISSIG0002",1061,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",604,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2074","PSIVISSIG0002",1062,55,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1676,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2075","PSIVISSIG0002",1063,43,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",92,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2076","PSIVISSIG0002",1064,51,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",145,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2077","PSIVISSIG0002",1065,47,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",170,1,"Censored at the last contact date","ADVERSE EVENT"
"2078","PSIVISSIG0002",1066,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",851,1,"Censored at the last contact date","ADVERSE EVENT"
"2079","PSIVISSIG0002",1067,45,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"2080","PSIVISSIG0002",1068,46,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",879,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2081","PSIVISSIG0002",1069,50,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",227,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2082","PSIVISSIG0002",1070,47,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",240,1,"Censored at the last contact date","DEATH"
"2083","PSIVISSIG0002",1071,33,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",880,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2084","PSIVISSIG0002",1072,54,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",183,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2085","PSIVISSIG0002",1073,31,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",211,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2086","PSIVISSIG0002",1074,42,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1750,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2087","PSIVISSIG0002",1075,40,"Positive",1,"Hormone receptor positive","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",12,1,"Censored at the last contact date","ADVERSE EVENT"
"2088","PSIVISSIG0002",1076,40,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"2089","PSIVISSIG0002",1077,40,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",897,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2090","PSIVISSIG0002",1078,35,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",657,1,"Censored at the last contact date","ADVERSE EVENT"
"2091","PSIVISSIG0002",1079,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",376,1,"Censored at the last contact date","ADVERSE EVENT"
"2092","PSIVISSIG0002",1080,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1776,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2093","PSIVISSIG0002",1081,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",622,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2094","PSIVISSIG0002",1082,33,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1436,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2095","PSIVISSIG0002",1083,45,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1271,1,"Censored at the last contact date","ADVERSE EVENT"
"2096","PSIVISSIG0002",1084,43,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"2097","PSIVISSIG0002",1085,48,"Positive",1,"Hormone receptor positive","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",448,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2098","PSIVISSIG0002",1086,52,"Negative",2,"Hormone receptor negative","No",1,"No prior radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1597,1,"Censored at the last contact date","PROGRESSIVE DISEASE"
"2099","PSIVISSIG0002",1087,36,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",1780,0,"NA",""
"2100","PSIVISSIG0002",1088,48,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 52 weeks",1,"Progression-free survival (days)","PFS",230,1,"Censored at the last contact date","ADVERSE EVENT"
"2101","PSIVISSIG0002",1089,51,"Negative",2,"Hormone receptor negative","Yes",2,"Prior Radiotherapy","tablemab x 12 week -> vismab 34 weeks",3,"Progression-free survival (days)","PFS",1780,0,"NA",""
